Document and Entity Information
Document and Entity Information - shares | 6 Months Ended | |
Jun. 30, 2016 | Aug. 02, 2016 | |
Document And Entity Information [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Jun. 30, 2016 | |
Document Fiscal Year Focus | 2,016 | |
Document Fiscal Period Focus | Q2 | |
Trading Symbol | MMI | |
Entity Registrant Name | Marcus & Millichap, Inc. | |
Entity Central Index Key | 1,578,732 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 37,607,636 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2016 | Dec. 31, 2015 |
Current assets: | ||
Cash and cash equivalents | $ 92,437 | $ 96,185 |
Commissions receivable | 4,549 | 3,342 |
Prepaid expenses | 5,474 | 7,542 |
Income tax receivable | 0 | 4,049 |
Marketable securities, available-for-sale | 81,775 | 79,860 |
Other assets, net | 4,938 | 5,136 |
Total current assets | 189,173 | 196,114 |
Prepaid rent | 11,483 | 9,075 |
Property and equipment, net | 14,303 | 11,579 |
Marketable securities, available-for-sale | 64,178 | 54,395 |
Assets held in rabbi trust | 7,106 | 5,661 |
Deferred tax assets, net | 33,903 | 35,285 |
Other assets | 9,657 | 9,116 |
Total assets | 329,803 | 321,225 |
Current liabilities: | ||
Accounts payable and accrued expenses | 8,343 | 9,135 |
Notes payable to former stockholders | 986 | 939 |
Commissions payable | 23,540 | 34,091 |
Income tax payable | 5,303 | 0 |
Accrued bonuses and other employee related expenses | 14,995 | 30,846 |
Total current liabilities | 53,167 | 75,011 |
Deferred compensation and commissions | 38,580 | 43,678 |
Notes payable to former stockholders | 8,686 | 9,671 |
Deferred rent and other liabilities | 4,336 | 3,875 |
Total liabilities | 104,769 | 132,235 |
Commitments and contingencies | ||
Stockholders' equity: | ||
Preferred stock, $0.0001 par value: Authorized shares - 25,000,000; issued and outstanding shares - none at June 30, 2016, and December 31, 2015, respectively | 0 | 0 |
Common stock, $0.0001 par value: Authorized shares - 150,000,000; issued and outstanding shares - 37,607,636 and 37,396,456 at June 30, 2016, and December 31, 2015, respectively | 4 | 4 |
Additional paid-in capital | 83,155 | 80,591 |
Stock notes receivable from employees | (4) | (4) |
Retained earnings | 140,281 | 107,942 |
Accumulated other comprehensive income | 1,598 | 457 |
Total stockholders' equity | 225,034 | 188,990 |
Total liabilities and stockholders' equity | $ 329,803 | $ 321,225 |
Condensed Consolidated Balance3
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares | Jun. 30, 2016 | Dec. 31, 2015 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized | 25,000,000 | 25,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 150,000,000 | 150,000,000 |
Common stock, shares issued | 37,607,636 | 37,396,456 |
Common stock, shares outstanding | 37,607,636 | 37,396,456 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Net and Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2016 | Jun. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2015 | |
Revenues: | ||||
Real estate brokerage commissions | $ 170,118 | $ 160,221 | $ 323,782 | $ 294,414 |
Financing fees | 10,726 | 11,150 | 19,459 | 19,181 |
Other revenues | 2,543 | 2,111 | 4,418 | 6,428 |
Total revenues | 183,387 | 173,482 | 347,659 | 320,023 |
Operating expenses: | ||||
Cost of services | 113,126 | 105,557 | 209,279 | 191,715 |
Selling, general and administrative expense | 40,420 | 37,589 | 82,675 | 73,418 |
Depreciation and amortization expense | 1,009 | 807 | 2,015 | 1,587 |
Total operating expenses | 154,555 | 143,953 | 293,969 | 266,720 |
Operating income | 28,832 | 29,529 | 53,690 | 53,303 |
Other income (expense), net | 618 | 362 | 848 | 487 |
Interest expense | (384) | (386) | (775) | (969) |
Income before provision for income taxes | 29,066 | 29,505 | 53,763 | 52,821 |
Provision for income taxes | 11,542 | 11,949 | 21,424 | 21,596 |
Net income | 17,524 | 17,556 | 32,339 | 31,225 |
Other comprehensive income (loss): | ||||
Unrealized gain (loss) on marketable securities, net of tax of $271, $332, $721 and $206 for the three months ended June 30, 2016, and 2015 and the six months ended June 30, 2016, and 2015, respectively | 426 | (493) | 1,106 | (305) |
Foreign currency translation (loss) gain, net of tax of $0, $31, $0 and $86 for the three months ended June 30, 2016, and 2015 and the six months ended June 30, 2016, and 2015, respectively | (12) | (46) | 35 | 127 |
Total other comprehensive income | 414 | (539) | 1,141 | (178) |
Comprehensive income | $ 17,938 | $ 17,017 | $ 33,480 | $ 31,047 |
Earnings per share: | ||||
Basic | $ 0.45 | $ 0.45 | $ 0.83 | $ 0.80 |
Diluted | $ 0.45 | $ 0.45 | $ 0.83 | $ 0.80 |
Weighted average common shares outstanding: | ||||
Basic | 38,918 | 38,870 | 38,905 | 38,858 |
Diluted | 39,054 | 39,057 | 39,008 | 39,006 |
Condensed Consolidated Stateme5
Condensed Consolidated Statements of Net and Comprehensive Income (Unaudited) (Parenthetical) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2016 | Jun. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2015 | |
Income Statement [Abstract] | ||||
Unrealized gain (loss) on marketable securities, tax | $ 271 | $ 332 | $ 721 | $ 206 |
Foreign currency translation (loss) gain, tax | $ 0 | $ 31 | $ 0 | $ 86 |
Condensed Consolidated Stateme6
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - 6 months ended Jun. 30, 2016 - USD ($) $ in Thousands | Total | Preferred Stock [Member] | Common Stock [Member] | Additional Paid-In Capital [Member] | Stock Notes Receivable From Employees [Member] | Retained Earnings [Member] | Accumulated Other Comprehensive Income [Member] |
Beginning Balance at Dec. 31, 2015 | $ 188,990 | $ 0 | $ 4 | $ 80,591 | $ (4) | $ 107,942 | $ 457 |
Beginning Balance, Shares at Dec. 31, 2015 | 0 | 37,396,456 | |||||
Net and comprehensive income | 33,480 | $ 0 | $ 0 | 0 | 0 | 32,339 | 1,141 |
Stock-based compensation | 3,100 | $ 0 | $ 0 | 3,100 | 0 | 0 | 0 |
Stock-based compensation, Shares | 0 | 0 | |||||
Shares issued pursuant to employee stock purchase plan | 402 | $ 0 | $ 0 | 402 | 0 | 0 | 0 |
Shares issued pursuant to employee stock purchase plan, Shares | 0 | 17,940 | |||||
Issuance of common stock for unvested restricted stock awards | 0 | $ 0 | $ 0 | 0 | 0 | 0 | 0 |
Issuance of common stock for unvested restricted stock awards, Shares | 0 | 14,742 | |||||
Issuance of common stock for vesting of restricted stock units | 0 | $ 0 | $ 0 | 0 | 0 | 0 | 0 |
Issuance of common stock for vesting of restricted stock units, Shares | 0 | 218,906 | |||||
Shares withheld related to net share settlement of stock-based awards, units | $ (1,109) | $ 0 | $ 0 | (1,109) | 0 | 0 | 0 |
Shares withheld related to net share settlement of stock-based awards, shares | (40,408) | 0 | (40,408) | ||||
Windfall tax benefit from stock-based award activity | $ 171 | $ 0 | $ 0 | 171 | 0 | 0 | 0 |
Ending Balance at Jun. 30, 2016 | $ 225,034 | $ 0 | $ 4 | $ 83,155 | $ (4) | $ 140,281 | $ 1,598 |
Ending Balance, Shares at Jun. 30, 2016 | 0 | 37,607,636 |
Condensed Consolidated Stateme7
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2016 | Jun. 30, 2015 | |
Cash flows from operating activities | ||
Net income | $ 32,339 | $ 31,225 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization expense | 2,015 | 1,587 |
Provision for bad debt expense | 3 | 79 |
Stock-based compensation | 3,100 | 4,582 |
Deferred taxes, net | 661 | 1,203 |
Net realized losses (gains) on marketable securities, available-for-sale | 135 | (130) |
Tax benefit from stock-based award activity | 171 | 4,834 |
Excess tax benefit from stock-based award activity | (171) | (4,834) |
Other non-cash items | 243 | (16) |
Changes in operating assets and liabilities: | ||
Commissions receivable | (1,207) | (1,719) |
Prepaid expenses | 2,068 | 1,030 |
Prepaid rent | (2,408) | (1,691) |
Contributions to rabbi trust | (1,263) | (1,368) |
Other assets | (216) | (2,244) |
Accounts payable and accrued expenses | (1,533) | (106) |
Income tax receivable/payable | 9,352 | 7,097 |
Commissions payable | (10,551) | (7,120) |
Accrued bonuses and other employee related expenses | (15,653) | (11,473) |
Deferred compensation and commissions | (5,286) | (152) |
Deferred rent obligation and other liabilities | 461 | 1,083 |
Net cash provided by operating activities | 12,260 | 21,867 |
Cash flows from investing activities | ||
Purchases of marketable securities, available-for-sale | (60,839) | (98,262) |
Proceeds from sales and maturities of marketable securities, available-for-sale | 50,847 | 10,023 |
Payments received on employee notes receivable | 2 | 0 |
Issuances of employee notes receivable | (307) | (99) |
Purchase of property and equipment | (4,252) | (2,201) |
Proceeds from sale of property and equipment | 15 | 0 |
Net cash used in investing activities | (14,534) | (90,539) |
Cash flows from financing activities | ||
Proceeds from issuance of shares pursuant to employee stock purchase plan | 402 | 502 |
Taxes paid related to net share settlement of stock-based awards | (1,109) | (731) |
Excess tax benefit from stock-based award activity | 171 | 4,834 |
Principal payments on notes payable to former stockholders | (938) | (894) |
Net cash (used in) provided by financing activities | (1,474) | 3,711 |
Net decrease in cash and cash equivalents | (3,748) | (64,961) |
Cash and cash equivalents at beginning of period | 96,185 | 149,159 |
Cash and cash equivalents at end of period | 92,437 | 84,198 |
Supplemental disclosures of cash flow information | ||
Interest paid during the period | 563 | 803 |
Income taxes paid, net | 11,240 | 8,463 |
Supplemental disclosures of noncash investing and financing activities | ||
Reduction of accrued bonuses and other employee related expenses in settlement of employee notes receivable | 198 | 208 |
Change in property and equipment included in accounts payable and accrued expenses | 741 | 305 |
Settlements of deferred compensation obligation with trust assets | $ 0 | $ 19 |
Description of business, basis
Description of business, basis of presentation and recent accounting pronouncements | 6 Months Ended |
Jun. 30, 2016 | |
Accounting Policies [Abstract] | |
Description of business, basis of presentation and recent accounting pronouncements | 1. Description of business, basis of presentation and recent accounting pronouncements Description of Business Marcus & Millichap, Inc., (the “Company”, “Marcus & Millichap”, or “MMI”), a Delaware corporation, is a brokerage firm specializing in commercial real estate investment sales, financing, research and advisory services. As of June 30, 2016, MMI operates 81 offices in the United States and Canada through its wholly-owned subsidiary, Marcus & Millichap Real Estate Investment Services, Inc. (“MMREIS”), which includes the operations of Marcus & Millichap Capital Corporation (“MMCC”). Reorganization and Initial Public Offering MMI was formed in June 2013 in preparation for Marcus & Millichap Company (“MMC”) to spin-off its majority owned subsidiary, MMREIS (“Spin-Off”). Prior to the initial public offering (“IPO”) of MMI, all of the preferred and common stockholders of MMREIS (including MMC and employees of MMREIS) contributed all of their outstanding shares to MMI in exchange for new MMI common stock. As a result, MMREIS became a wholly-owned subsidiary of MMI. Thereafter, MMC distributed 80.0% of the shares of MMI common stock to MMC’s shareholders and exchanged the remaining portion of its shares of MMI common stock for cancellation of indebtedness of MMC. MMI completed its IPO on October 30, 2013. Basis of Presentation The financial information presented in the accompanying unaudited condensed consolidated financial statements, has been prepared in accordance with rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for quarterly reports on Form 10-Q and Article 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. generally accepted accounting principles (“U.S. GAAP”) for complete financial statements. In the opinion of management, the accompanying unaudited condensed consolidated financial statements and notes include all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation of the consolidated financial position, results of operations and cash flows for the periods presented. These unaudited condensed consolidated financial statements should be read in conjunction with the annual audited consolidated financial statements and notes thereto for the year ended December 31, 2015 included in the Company’s Annual Report on Form 10-K filed on March 15, 2016 with the SEC. The results of the three and six months ended June 30, 2016 are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2016, or for other interim periods or future years. Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosures at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Reclassifications Certain prior-period amounts have been reclassified to conform to the current period presentation. These changes had no impact on the previously reported condensed consolidated results of operations, financial condition, stockholders’ equity or on cash flows subtotals. Concentration of Credit Risk Financial instruments that potentially subject the Company to a concentration of credit risk principally consist of cash and cash equivalents, due from independent contractors (included under other assets, net current and other assets non-current captions), investments in marketable securities, available-for-sale, security deposits (included under other assets, non-current caption) and commissions receivables. Cash is placed with high-credit quality financial institutions and invested high-credit quality money market funds. To reduce its credit risk, the Company monitors the credit standing of the financial institutions that hold the Company’s cash and cash equivalents. The Company historically has not experienced any losses related to cash and cash equivalents. The Company derives its revenues from a broad range of real estate investors, owners and users in the United States and Canada, none of which individually represents a significant concentration of credit risk. The Company performs credit evaluations of its customers and debtors and requires collateral on a case-by-case basis. The Company maintains allowances, as needed, for estimated credit losses based on management’s assessment of the likelihood of collection. For the three and six months ended June 30, 2016 and 2015, no transaction represented 10% or more of total revenues. Further, while one or more transactions may represent 10% or more of commissions receivable at any reporting date, amounts due are typically collected within 10 days of settlement and therefore do not expose the Company to significant credit risk. The Company’s Canadian operations represented less than 1.0% of total revenues in each period presented. Recent Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date Revenue from Contacts with Customers: Principal Versus Agent Considerations Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing Revenue from Contracts with Customers: Narrow-Scope Improvements and Practical Expedients ASU 2014-09 permits two implementation approaches, one requiring retrospective application of the new standard with restatement of prior years and one requiring prospective application of the new standard with disclosure of results under old standards. For the Company, the new standard will be effective January 1, 2018. The Company does not have multiple-element arrangements, variable consideration, licenses and long-term contracts with customers. Accordingly, the Company does not expect this standard to have a significant effect in the manner or timing of its revenue recognition. The Company is in the process of completing the evaluation of the impact of this new standard and will select a transition method when the effect is determined. In August 2014, the FASB issued ASU No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern In February 2016, the FASB issued ASU No. 2016-02, Leases In March 2016, the FASB issued ASU No. 2016-09, Improvements to Employee Share-Based Payment Accounting 1. Accounting for income taxes upon vesting or settlement of awards 2. Presentation of excess tax benefits on the statement of cash flows 3. Accounting for forfeitures 4. Minimum statutory withholding requirements 5. Presentation of employee taxes paid on the statement of cash flows when an employer withholds shares to meet minimum statutory withholding requirements 6. Private company practical expedients ASU 2016-09 is effective for reporting periods beginning after December 15, 2016 and early adoption is permitted. For the Company, the new standard will be effective January 1, 2017. The Company is currently evaluating the impact of ASU 2016-09 and timeframe for adoption. Since the Company issues stock-based awards to its employees and independent contractors and has recognized windfall tax benefits in additional paid in capital, it is anticipated that the ASU, when adopted, will impact (i) the Company’s provision for income taxes, and therefore net and comprehensive income and related earnings per share amounts, (ii) amounts presented in the condensed consolidated statement of stockholders’ equity and condensed consolidated statements of cash flows and (iii) to a lesser extent the timing of our stock-based compensation expense. See Note 9 – “Stock-Based Compensation Plans” for additional information. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses |
Property and Equipment
Property and Equipment | 6 Months Ended |
Jun. 30, 2016 | |
Property, Plant and Equipment [Abstract] | |
Property and Equipment | 2. Property and Equipment Property and equipment, net consist of the following (in thousands): June 30, December 31, Computer software and hardware equipment $ 12,399 $ 10,973 Furniture, fixtures, and equipment 19,109 17,047 Less: accumulated depreciation and amortization (17,205 ) (16,441 ) $ 14,303 $ 11,579 During the six months ended June 30, 2016 and 2015, the Company wrote off approximately $1.5 million and $2.0 million, respectively, of fully depreciated computer software and hardware and furniture, fixtures and equipment. The Company leases all of its facilities under operating lease agreements. Lease agreements may contain periods of free rent or reduced rent or contain predetermined fixed increases in the minimum rent. The Company recognizes the minimum lease payments as rent expense on a straight-line basis over the noncancellable term of the lease. The Company records the difference between the amount charged to rent expense and the rent paid as a deferred rent obligation. The Company typically leases general purpose built-out office space, which reverts to the lessor upon termination of the lease. Any payments for improvements, net of incentives received, are recorded as prepaid rent. Prepaid rent is amortized using the straight-line method over the expected lease term as a charge to rent expense. |
Selected Balance Sheet Data
Selected Balance Sheet Data | 6 Months Ended |
Jun. 30, 2016 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Selected Balance Sheet Data | 3. Selected Balance Sheet Data Other Assets Other assets consisted of the following (in thousands): Current Non-Current June 30, December 31, June 30, December 31, 2016 2015 2016 2015 Due from independent contractors, net (1) (2) $ 1,857 $ 2,545 $ 8,142 $ 7,358 Security deposits — — 1,073 1,425 Employee notes receivable (3) 364 224 112 158 Customer trust accounts and other 2,717 2,367 330 175 $ 4,938 $ 5,136 $ 9,657 $ 9,116 (1) Represents amounts advanced, notes receivable and other receivables due from the Company’s investment sales and financing professionals. The notes receivable along with interest, are typically collected from future commissions and are generally due in one to five years. (2) Includes allowance for doubtful accounts related to current receivables of $297 and $359 as of June 30, 2016 and December 31, 2015, respectively. The Company recorded a (recovery) provision for bad debt expense of $(13) and $58 and wrote off $11 and $29 of these receivables for the three months ended June 30, 2016 and 2015, respectively. The Company recorded a provision for bad debt expense of $3 and $79 and wrote off $65 and $35 of these receivables for the six months ended June 30, 2016 and 2015, respectively. (3) See Note 6 – “Related-Party Transactions” for additional information. Deferred Compensation and Commissions Deferred compensation and commissions consisted of the following (in thousands): June 30, December 31, SARs liability $ 21,856 $ 21,399 Commissions payable to investment sales and financing professionals 10,010 17,015 Deferred compensation liability 6,714 5,264 $ 38,580 $ 43,678 SARs Liability Prior to the IPO, certain employees of the Company were granted stock appreciation rights (“SARs”) under a stock-based compensation program assumed by MMC. In connection with the IPO, the SARs agreements were revised, the MMC liability of $20.0 million for the SARs was frozen at March 31, 2013, and was transferred to MMI through a capital distribution. The SARs liability will be settled with each participant in installments upon retirement or termination from service. Under the revised agreements, MMI is required to accrue interest on the outstanding balance beginning on January 1, 2014 at a rate based on the 10-year treasury note plus 2%. The rate resets annually. The rates at January 1, 2016 and 2015 were 4.273% and 4.173%, respectively. MMI recorded interest expense related to this liability of $228,000 and $214,000, for the three months ended June 30, 2016 and 2015, respectively and $457,000 and $428,000 for the six months ended June 30, 2016 and 2015, respectively. Commissions Payable Certain investment sales professionals have the ability to earn additional commissions after meeting certain annual revenue thresholds. These commissions are recognized as cost of services in the period in which they are earned. The Company has the ability to defer payment of certain commissions, at its election, for up to three years. Commissions payable that are not expected to be paid within twelve months are classified as long-term. Deferred Compensation Liability A select group of management is eligible to participate in a Deferred Compensation Plan. The plan is a 409A plan and permits the participant to defer compensation up to limits as determined by the plan. The Company elected to fund the Deferred Compensation Plan through company owned variable life insurance policies. The Deferred Compensation Plan is managed by a third-party institutional fund manager, and the deferred compensation and investment earnings are held as a Company asset in a rabbi trust, which is recorded in assets held in rabbi trust in the accompanying condensed consolidated balance sheets. The assets in the trust are restricted unless the Company becomes insolvent, as defined in the Deferred Compensation Plan, in which case the trust assets are subject to the claims of MMI’s creditors. The Company may also, in its sole and absolute discretion, elect to withdraw at any time a portion of the trust assets by an amount by which the fair market value of the trust assets exceeds 110% of the aggregate deferred compensation liability represented by the participants’ accounts. The net change in the carrying value of the assets held in the rabbi trust and the net change in the carrying value of the deferred compensation liability, each exclusive of additional contributions, distributions and trust expenses consisted of the following (in thousands): Three Months Ended Six Months Ended June 30, 2016 2015 2016 2015 Increase (decrease) in the carrying value of the assets held in the rabbi trust (1) $ 150 $ (104 ) $ 184 $ 11 Increase (decrease) in the carrying value of the deferred compensation (2) $ 151 $ (94 ) $ 188 $ 59 (1) Recorded in other income (expense), net in the condensed consolidated statements of net and comprehensive income. (2) Recorded in selling, general and administrative expense in the condensed consolidated statements of net and comprehensive income. |
Investments in Marketable Secur
Investments in Marketable Securities | 6 Months Ended |
Jun. 30, 2016 | |
Investments, Debt and Equity Securities [Abstract] | |
Investments in Marketable Securities | 4. Investments in Marketable Securities Amortized cost and fair value of marketable securities, available-for-sale, by type of security consisted of the following (in thousands): June 30, 2016 December 31, 2015 Amortized Gross Gross Fair Value Amortized Gross Gross Fair Value Short-term investments: U.S. Treasuries $ 53,278 $ 35 $ — $ 53,313 $ 62,343 $ — $ (71 ) $ 62,272 U.S. Government Sponsored Entities 8,509 7 — 8,516 17,571 — (12 ) 17,559 Corporate debt securities 19,939 7 — 19,946 29 — — 29 $ 81,726 $ 49 $ — $ 81,775 $ 79,943 $ — $ (83 ) $ 79,860 Long-term investments: U.S. Treasuries $ 21,176 $ 250 $ — $ 21,426 $ 15,283 $ — $ (112 ) $ 15,171 U.S. Government Sponsored Entities 15,919 48 — 15,967 12,107 — (85 ) 12,022 Corporate debt securities 16,412 503 (39 ) 16,876 17,219 5 (519 ) 16,705 Asset-backed securities and other 9,839 128 (58 ) 9,909 10,649 — (152 ) 10,497 $ 63,346 $ 929 $ (97 ) $ 64,178 $ 55,258 $ 5 $ (868 ) $ 54,395 The amortized cost and fair value of the Company’s investments in available-for-sale securities that have been in a continuous unrealized loss position consisted of the following (in thousands): June 30, 2016 December 31, 2015 Unrealized Fair Value Unrealized Fair Value Less than 12 months $ (72 ) $ 4,607 $ (951 ) $ 129,117 12 months or longer $ (25 ) $ 1,879 $ — $ — Gross realized gains and gross realized losses from the sales of the Company’s available-for-sale securities consisted of the following (in thousands): Three Months Ended Six Months Ended 2016 2015 2016 2015 Gross realized gain (1) $ 20 $ 56 $ 20 $ 133 Gross realized loss (1) $ — $ — $ (155 ) $ (3 ) (1) Recorded in other income (expense), net in the condensed consolidated statements of net and comprehensive income. The cost basis of securities sold were determined on the specific identification method. The Company may sell certain of its marketable securities, available-for-sale prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration, duration management and when a security no longer meets the criteria of the Company’s investment policy. During the six months ended June 30, 2016, the Company sold one security, which no longer met the requirements of its investment policy, for a loss of $152,000. The Company considers the declines in market value of its marketable securities, available-for-sale to be temporary in nature and does not consider any of its investments other-than-temporarily impaired. The Company typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy generally requires investments to be investment grade, with the primary objective of minimizing the potential risk of principal loss and matching long-term liabilities. When evaluating an investment for other-than-temporary impairment the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates and the Company’s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment’s cost basis. Amortized cost and fair value of marketable securities, available-for-sale, by contractual maturity consisted of the following (in thousands): June 30, 2016 December 31, 2015 Amortized Fair Value Amortized Fair Value Due in one year or less $ 81,726 $ 81,775 $ 79,943 $ 79,860 Due after one year through five years 40,259 40,473 28,634 28,465 Due after five years through ten years 15,002 15,529 18,020 17,466 Due after ten years 8,085 8,176 8,604 8,464 $ 145,072 $ 145,953 $ 135,201 $ 134,255 Weighted average contractual maturity 3.0 years 3.3 years Actual maturities may differ from contractual maturities because certain borrowers have the right to prepay certain obligations with or without prepayment penalties. |
Notes Payable to Former Stockho
Notes Payable to Former Stockholders | 6 Months Ended |
Jun. 30, 2016 | |
Payables and Accruals [Abstract] | |
Notes Payable to Former Stockholders | 5. Notes Payable to Former Stockholders In conjunction with the Spin-Off and IPO, notes payable to certain former stockholders of MMREIS were issued in settlement of restricted stock and SARs awards that were redeemed by MMREIS upon the termination of employment by these former stockholders (“the Notes”), which had been previously assumed by MMC, and were transferred to the Company. The Notes are unsecured and bear interest at 5% with annual principal and interest installments and a final principal payment due during the second quarter of 2020. During each of the six months ended June 30, 2016 and 2015, the Company made total payments on the Notes of $1.5 million. Accrued interest pertaining to the Notes consisted of the following (in thousands): June 30, 2016 December 31, Accrued interest (1) $ 94 $ 367 (1) Recorded in accounts payable and accrued expenses in the accompanying condensed consolidated balance sheets. Interest expense pertaining to the Notes consisted of the following (in thousands): Three Months Ended Six Months Ended 2016 2015 2016 2015 Interest expense $ 126 $ 137 $ 259 $ 281 |
Related-Party Transactions
Related-Party Transactions | 6 Months Ended |
Jun. 30, 2016 | |
Related Party Transactions [Abstract] | |
Related-Party Transactions | 6. Related-Party Transactions Shared and Transition Services Prior to October 2013, the Company operated under a shared services arrangement with MMC whereby the Company was charged for actual costs specifically incurred on behalf of the Company or allocated to the Company on a pro rata basis. Beginning in October 2013, certain services are provided to the Company under a Transition Services Agreement (“TSA”) between MMC and the Company, which replaced the pre-IPO shared services arrangement. The TSA is intended to provide certain services until the Company acquires the services separately. During the three months ended June 30, 2016 and 2015, the Company incurred $54,000 and $59,000 under the TSA. During the six months ended June 30, 2016 and 2015, the Company incurred $124,000 and $109,000 under the TSA. These amounts are included in selling, general and administrative expense in the accompanying condensed consolidated statements of net and comprehensive income. As of June 30, 2016 and December 31, 2015, $103,000 and $96,000, respectively, remains unpaid and is included in accounts payable and accrued expenses in the accompanying condensed consolidated balance sheets. Brokerage and Financing Services with the Subsidiaries of MMC MMC has wholly or majority owned subsidiaries that buy and sell commercial real estate properties. The Company performs certain brokerage and financing services related to transactions of the subsidiaries of MMC. For the three months ended June 30, 2016 and 2015, the Company generated real estate brokerage commissions and financing fees of $793,000 and $238,000, respectively, from subsidiaries of MMC. The Company incurred cost of services of $476,000 and $143,000, respectively, related to these revenues. For the six months ended June 30, 2016 and 2015, the Company generated real estate brokerage commissions and financing fees of $2.4 million and $1.3 million, respectively, from subsidiaries of MMC. The Company incurred cost of services of $1.4 million and $770,000, respectively, related to these revenues. Operating Lease with MMC The Company has an operating lease with MMC for a single story office building located in Palo Alto, California, which was amended in 2016 to extend the expiration date to May 31, 2022. Rent expense for this lease aggregated $253,000 and $146,000 for the three months ended June 30, 2016 and 2015, respectively. Rent expense for this lease aggregated $506,000 and $255,500 for the six months ended June 30, 2016 and 2015, respectively. Rent expense is included in selling, general and administrative expense in the accompanying condensed consolidated statements of net and comprehensive income. Other The Company makes advances to non-executive employees from time-to-time. At June 30, 2016 and December 31, 2015, the aggregate principal amount for employee loans outstanding was $476,000 and $382,000, respectively, which is included in other assets, net current and other assets non-current captions in the accompanying condensed consolidated balance sheets. As of June 30, 2016, George M. Marcus, the Company’s founder and Co-Chairman, beneficially owned 55.2% of the Company’s issued and outstanding common stock, including shares owned by Phoenix Investments Holdings, LLC (“Phoenix”) and the George and Judy Marcus Family Foundation. |
Fair Value Measurements
Fair Value Measurements | 6 Months Ended |
Jun. 30, 2016 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | 7. Fair Value Measurements U.S. GAAP defines the fair value of a financial instrument as the amount that would be received from the sale of an asset in an orderly transaction between market participants at the measurement date. The Company is responsible for the determination of the value of the investment carried and fair value and the supporting methodologies and assumptions. The Company uses various pricing sources to validate the values utilized. The degree of judgment used in measuring the fair value of financial instruments is generally inversely correlates with the level of observable valuation inputs. Financial instruments with quoted prices in active markets generally have more pricing observability and less judgment is used in measuring fair value. Financial instruments for which no quoted prices are available have less observability and are measured at fair value using valuation models or other pricing techniques that require more judgment. Assets recorded at fair value are measured and classified in accordance with a fair value hierarchy consisting of the three “levels” based on the observability of inputs available in the marketplace used to measure the fair values as discussed below: Level 1: Level 2: Level 3: Recurring Fair Value Measurements The Company values its investments including assets held in rabbi trust, money market funds and investments in marketable securities, available-for-sale at fair value on a recurring basis. Investments carried at fair value are categorized into one of the three categories described above and consisted of the following (in thousands): June 30, 2016 December 31, 2015 Fair Level 1 Level 2 Level 3 Fair Level 1 Level 2 Level 3 Assets held in rabbi trust $ 7,106 $ — $ 7,106 $ — $ 5,661 $ — $ 5,661 $ — Money market funds (1) $ 56,802 $ 56,802 $ — $ — $ 5,987 $ 5,987 $ — $ — Marketable securities, available-for-sale: Short-term investments: U.S. Treasuries $ 53,313 $ 53,313 $ — $ — $ 62,272 $ 62,272 $ — $ — U.S. Government Sponsored Entities 8,516 — 8,516 — 17,559 — 17,559 — Corporate debt securities 19,946 — 19,946 — 29 — 29 — $ 81,775 $ 53,313 $ 28,462 $ — $ 79,860 $ 62,272 $ 17,588 $ — Long-term investments: U.S. Treasuries $ 21,426 $ 21,426 $ — $ — $ 15,171 $ 15,171 $ — $ — U.S. Government Sponsored Entities 15,967 — 15,967 — 12,022 — 12,022 — Corporate debt securities 16,876 — 16,876 — 16,705 — 16,705 — Asset-backed securities and other 9,909 — 9,909 — 10,497 — 10,497 — $ 64,178 $ 21,426 $ 42,752 $ — $ 54,395 $ 15,171 $ 39,224 $ — (1) Included in cash and cash equivalents. There were no transfers in or out of Level 1 and Level 2 during the three and six months ended June 30, 2016. Assets and Liabilities not Measured at Fair Value The Company’s cash and cash equivalents, commissions receivable, amounts due from employees (included in other assets, net current and other assets non-current captions) and investment sales and financing professionals (included in other assets, net current caption), accounts payable and accrued expenses and commissions payable are carried at cost, which approximates fair value based on their immediate or short-term maturities and terms which approximate current market rates and are considered to be in the Level 1 classification. As the Company’s obligations under notes payable to former stockholders bear fixed interest rates that approximate current interest rates for debt instruments with similar terms and maturities, the Company has determined that the carrying value on these instruments approximates fair value. As the Company’s obligations under SARs liability (included in deferred compensation and commission’s caption) bear interest at a variable rate based on U.S. Treasuries, the Company has determined that the carrying value approximates the fair value. These are considered to be in the Level 2 classification. |
Stockholders' Equity
Stockholders' Equity | 6 Months Ended |
Jun. 30, 2016 | |
Equity [Abstract] | |
Stockholders' Equity | 8. Stockholders’ Equity Common Stock As of June 30, 2016 and December 31, 2015, there were 37,607,636 and 37,396,456 shares of common stock, $0.0001 par value, issued and outstanding, which includes unvested restricted stock awards issued to non-employee directors, respectively. See Note 11 – “Earnings per Share” for additional information. The Company currently does not intend to pay a regular dividend. The Company will evaluate its dividend policy in the future. Any declaration and payment of future dividends to holders of the Company’s common stock will be at the discretion of the board of directors and will depend on many factors, including the Company’s financial condition, earnings, cash flows, capital requirements, level of indebtedness, statutory and contractual restrictions applicable to the payment of dividends and other considerations that the board of directors deems relevant. Preferred Stock The Company has 25,000,000 authorized shares of preferred stock with a par value $0.0001 per share. At June 30, 2016 and December 31, 2015, there were no preferred shares issued or outstanding. Accumulated Other Comprehensive Income The components of accumulated other comprehensive income as of June 30, 2016, by component, net of income taxes consisted of the following (in thousands): Unrealized available-for- Foreign (2) Total Beginning balance, December 31, 2015 $ (568 ) $ 1,025 $ 457 Other comprehensive income before reclassifications 1,200 35 1,235 Amounts reclassified from accumulated other comprehensive income (1) (94 ) — (94 ) Net current-period other comprehensive income 1,106 35 1,141 Ending balance, June 30, 2016 $ 538 $ 1,060 $ 1,598 (1) Included as a component of other income (expense), net in the condensed consolidated statements of net and comprehensive income. The reclassifications were determined on a specific identification basis. (2) The Company has not provided for U.S. taxes on unremitted earnings of its foreign subsidiary as it is operating at a loss and has no earnings and profits to remit. As a result, deferred taxes were not provided related to the cumulative foreign currency translation adjustments. |
Stock-Based Compensation Plans
Stock-Based Compensation Plans | 6 Months Ended |
Jun. 30, 2016 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Stock-Based Compensation Plans | 9. Stock-Based Compensation Plans 2013 Omnibus Equity Incentive Plan In October 2013, the board of directors adopted the 2013 Plan, which became effective upon the Company’s IPO. The 2013 Plan, in general, authorizes for the granting of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards (“RSAs”), restricted stock units (“RSUs”), performance units and performance shares to the Company’s and subsidiary corporations’ employees, independent contractors, directors and consultants. Grants are made from time to time by the Company’s board of directors at its discretion subject to certain restrictions as to the number and value of shares that may be granted to any individual. Upon adoption of the 2013 Plan, 5,500,000 shares of common stock were reserved for the issuance of awards under the 2013 Plan. Pursuant to the automatic increase provided for in the 2013 Plan, the board of directors have approved share reserve increases aggregating 2,200,000. As of June 30, 2016, there were 4,383,914 shares available for future grants under the Plan. Awards Granted in Connection with the IPO In November 2013, MMI issued the following equity awards under the 2013 Plan: (i) Deferred stock units (“DSUs”) for an aggregate of 2,192,413 shares granted as replacement awards related to the prior SARs program to the MMREIS managing directors and (ii) DSUs for 83,334 shares granted to the Company’s Co-chairman of the board of directors, William A. Millichap. The DSU’s are fully vested and shares will be issued ratably over 5 years (see “Amendments to Restricted Stock and SARs” section below). In addition, 30,000 shares, in the form of RSAs, were granted to the Company’s non-employee directors. The shares vest ratably over 3 years. All the above awards were granted based on the IPO price of $12.00. Awards Granted and Settled Subsequent to the IPO Under the 2013 Plan, the Company has issued RSA’s to non-employee directors and RSU’s to employees and independent contractors. All RSAs vest in equal annual installments over a three year period from the date of grant. All RSUs vest in equal annual installments over a five year period from the date of grant. Any unvested awards are canceled upon termination of service. Awards accelerate upon death subject to approval by the compensation committee. During the six months ended June 30, 2016, 229,904 shares of RSAs and RSUs vested and 40,408 shares of common stock were withheld to pay applicable required employee statutory withholding taxes based on the market value of the shares on the vesting date. The amount remitted to the tax authorities for the employees’ tax obligation was reflected in the taxes paid related to net share settlement of stock-based awards caption in the financing section of the condensed consolidated statements of cash flows. The shares withheld for taxes were returned to the share reserve and are available for future issuance in accordance with provisions of the 2013 Plan. During the six months ended June 30, 2016, the Company recorded windfall tax benefits, net in the amount of $171,000 resulting from settlement of stock-based award activity. Such windfall tax benefits, net, are excluded from the provision for income taxes, and included as a component of additional paid-in capital in the accompanying condensed consolidated balance sheets and in cash flows provided by (used in) financing activities in the accompanying condensed consolidated statement of cash flows. Outstanding Awards Activity under the 2013 Plan consisted of the following (dollars in thousands, except per share data): RSA Grants to RSU Grants to RSU Grants to Total Weighted- Nonvested shares at December 31, 2015 35,364 468,969 521,780 1,026,113 $ 21.17 Granted February 2016 — 172,496 8,856 181,352 March 2016 — 30,000 — 30,000 May 2016 14,742 11,051 8,188 33,981 Total Granted 14,742 213,547 17,044 245,333 23.18 Vested (10,998 ) (101,040 ) (117,866 ) (229,904 ) 19.13 Transferred — — — — — Forfeited/canceled — (6,974 ) (4,135 ) (11,109 ) 21.50 Nonvested shares at June 30, (1) 39,108 574,502 416,823 1,030,433 $ 22.11 Unrecognized stock-based compensation expense as of June 30, 2016 (2) $ 705 $ 11,897 $ 8,556 $ 21,158 Weighted average remaining vesting period (years) as of June 30, 2016 2.09 3.81 2.80 3.35 (1) Nonvested RSU’s will be settled through the issuance of new shares of common stock. (2) The total unrecognized compensation expense is expected to be recognized over a weighted-average period of approximately 3.35 years. As of June 30, 2016, 1,365,445 fully vested DSUs remained outstanding. Employee Stock Purchase Plan In 2013, the Company adopted the 2013 Employee Stock Purchase Plan (“ESPP Plan”). The ESPP Plan qualifies under Section 423 of the IRS Code and provides for consecutive, non-overlapping 6-month offering periods. The offering periods generally start on the first trading day on or after May 15 and November 15 of each year. The first offering period began on May 15, 2014. Qualifying employees may purchase shares of the Company’s stock at a 10% discount based on the lower of the market price at the beginning or end of the offering period, subject to IRS limitations. The Company determined that the ESPP Plan was a compensatory plan and is required to expense the fair value of the awards over each 6-month offering period. The ESPP Plan has 366,667 shares of common stock reserved and 289,244 shares of common stock available for issuance as of June 30, 2016. The ESPP Plan provides for annual increases in the number of shares available for issuance under the ESPP. Pursuant to the provisions of the ESPP Plan, the board of directors determined a share reserve increase was not needed in 2015. As of June 30, 2016, total unrecognized compensation cost related to the ESPP Plan was $81,000 and is expected to be recognized over a weighted average period of 0.38 years. Amendments to Restricted Stock and SARs Restricted Stock In connection with the IPO, the formula settlement value of all outstanding shares of stock held by the plan participants was removed, and all such shares of stock are subject to sales restrictions that lapse at a rate of 20% per year for five years if the participant remains employed by the Company. In the event of death or termination of employment after reaching the age of 67, 100% of the shares of stock will be released from the resale restriction. 100% of the shares of stock will be released from the resale restriction upon the consummation of a change of control of the Company. SARs Prior to the IPO, certain employees were granted SARs. As of March 31, 2013, the outstanding SARs were frozen at the liability amount, and will be paid out to each participant in installments upon retirement or departure under the terms of the revised SARs agreements. To replace beneficial ownership in the SARs, the difference between the book value liability and the fair value of the awards was granted to plan participants in the form of DSUs, which were fully vested upon receipt and will be settled in actual stock at a rate of 20% per year if the participant remains employed by the Company during that period (otherwise all unsettled shares of stock upon termination from service will be settled five years from the termination date). In the event of death or termination of service after reaching the age of 67, 100% of the DSUs will be settled. Summary of Stock-Based Compensation Components of stock-based compensation included in selling, general and administrative expense in the condensed consolidated statements of net and comprehensive income consisted of the following (in thousands, except common stock price): Three Months Ended June 30, Six Months Ended June 30, 2016 2015 2016 2015 Employee stock purchase plan $ 60 $ 66 $ 108 $ 128 RSAs – non-employee directors 109 78 198 137 RSUs – employees 818 552 1,476 1,079 RSUs – independent contractors (1) 788 1,979 1,318 3,238 $ 1,775 $ 2,675 $ 3,100 $ 4,582 Common stock price at beginning of period $ 25.39 $ 37.48 $ 29.14 $ 33.25 Common stock price at end of period $ 25.41 $ 46.14 $ 25.41 $ 46.14 Increase (decrease) in stock price $ 0.02 $ 8.66 $ (3.73 ) $ 12.89 (1) The Company grants RSUs to independent contractors (i.e. investment sales and financing professionals), who are considered non-employees under ASC 718. Accordingly, such awards are required to be measured at fair value at the end of each reporting period until settlement. Stock-based compensation expense is therefore impacted by the changes in the Company’s common stock price during each reporting period. |
Income Taxes
Income Taxes | 6 Months Ended |
Jun. 30, 2016 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | 10. Income Taxes The Company’s effective tax rate for the three and six months ended June 30, 2016 was 39.7% and 39.8%, compared to 40.5% and 40.9% for the three and six months ended June 30, 2015. The Company provides for the effects of income taxes in interim financial statements based on the Company’s estimate of its annual effective tax rate for the full year, which is based on forecasted income by jurisdiction where the Company operates, adjusted for the tax effects of items that relate discretely to the period, if any. The difference between the statutory tax rate and the Company’s effective tax rate is largely attributable to state income taxes and a full valuation allowance with respect to the deferred tax assets of the Company’s Canadian operations. |
Earnings per Share
Earnings per Share | 6 Months Ended |
Jun. 30, 2016 | |
Earnings Per Share [Abstract] | |
Earnings per Share | 11. Earnings per Share The following table sets forth the computation of basic and diluted earnings per share for the three and six months ended June 30, 2016 and 2015, respectively (in thousands, except per share data): Three Months Ended June 30, Six Months Ended June 30, 2016 2015 2016 2015 Numerator (Basic and Diluted): Net income $ 17,524 $ 17,556 $ 32,339 $ 31,225 Denominator: Basic Weighted average common shares issued and outstanding 37,591 37,092 37,576 37,080 Deduct: Unvested RSAs (1) (38 ) (44 ) (36 ) (44 ) Add: Fully vested DSUs (2) 1,365 1,822 1,365 1,822 Weighted Average Common Shares Outstanding 38,918 38,870 38,905 38,858 Basic earnings per common share $ 0.45 $ 0.45 $ 0.83 $ 0.80 Diluted Weighted Average Common Shares Outstanding from above 38,918 38,870 38,905 38,858 Add: Dilutive effect of RSUs, RSAs & ESPP 136 187 103 148 Weighted Average Common Shares Outstanding 39,054 39,057 39,008 39,006 Diluted earnings per common share $ 0.45 $ 0.45 $ 0.83 $ 0.80 Antidilutive shares excluded from diluted earnings per common share (3) 244 59 449 535 (1) RSAs were issued and outstanding to the non-employee directors and have a three year vesting term subject to service requirements. See Note 9 – “Stock-Based Compensation Plans” for additional information. (2) Shares are included in weighted average common shares outstanding as the shares are fully vested but have not yet been delivered. See Note 8 – “Stockholders’ Equity” for additional information. (3) Primarily pertaining to RSU grants to the Company’s independent contractors. |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Jun. 30, 2016 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | 12. Commitments and Contingencies Credit Agreement On June 18, 2014, the Company entered into a Credit Agreement with Wells Fargo Bank, National Association (“Bank”), dated as of June 1, 2014 (the “Credit Agreement”). The Credit Agreement provides for a $60.0 million principal amount senior secured revolving credit facility that is guaranteed by all of the Company’s domestic subsidiaries (the “Credit Facility”), which, as amended, matures on June 1, 2018. The Company may borrow, repay and reborrow amounts under the Credit Facility until its maturity date, at which time all amounts outstanding under the Credit Facility must be repaid in full. Borrowings under the Credit Agreement are available for general corporate purposes and working capital. The Credit Facility includes a $10.0 million sublimit for the issuance of standby letters of credit, of which, $533,000 was utilized at June 30, 2016. Borrowings under the Credit Facility bear interest, at the Company’s option, at either the (i) Base Rate (defined as the highest of (a) the Bank’s prime rate, (b) the Federal Funds Rate plus 1.5% and (c) one-month LIBOR plus 1.5%), or (ii) at a variable rate between 0.875% and 1.125% above LIBOR, based upon the total funded debt to EBITDA ratio. In connection with executing the Credit Agreement, as amended, the Company paid bank fees and other expenses, which are being amortized over the remaining term of the Credit Agreement. The Company pays a commitment fee of up to 0.1% per annum, payable quarterly, based on the amount of unutilized commitments under the Credit Facility. The amortization and commitment fee is included in interest expense in the accompanying condensed consolidated statements of net and comprehensive income and was $29,000 and $34,000 during the three months ended June 30, 2016 and 2015, respectively and $59,000 and $68,000 during the six months ended June 30, 2016 and 2015, respectively. As of June 30, 2016, there were no amounts outstanding under the Credit Agreement. The Credit Facility contains customary covenants, including financial and other covenant reporting requirements and events of default. Financial covenants require the Company, on a combined basis with its guarantors, to maintain (i) an EBITDAR Coverage Ratio (as defined in the Credit Agreement) of not less than 1.25:1.0 as of each quarter end and (ii) total funded debt to EBITDA not greater than 2.0:1.0 as of each quarter end both on a rolling 4-quarter basis. The Credit Facility is secured by substantially all assets of the Company, including pledges of 100% of the stock or other equity interest of each subsidiary except for the capital stock of a controlled foreign corporation (as defined in the Internal Revenue Code). As of June 30, 2016, the Company was in compliance with all financial and non-financial covenants. Litigation The Company is subject to various legal proceedings and claims that arise in the ordinary course of business, some of which involve claims for damages that are substantial in amount. Most of these litigation matters are covered by insurance which contain deductibles, exclusions, claim limits and aggregate policy limits. While the ultimate liability for these legal proceeding cannot be determined, the Company reviews the need for its accrual for loss contingencies quarterly and records an accrual for litigation related losses where the likelihood of loss is both probable and estimable. The Company believes that the ultimate resolution of the legal proceedings will not have a material adverse effect on its financial condition or results of operations. The Company accrues legal fees for litigation as the legal services are provided. |
Description of business, basi20
Description of business, basis of presentation and recent accounting pronouncements (Policies) | 6 Months Ended |
Jun. 30, 2016 | |
Accounting Policies [Abstract] | |
Description of Business | Description of Business Marcus & Millichap, Inc., (the “Company”, “Marcus & Millichap”, or “MMI”), a Delaware corporation, is a brokerage firm specializing in commercial real estate investment sales, financing, research and advisory services. As of June 30, 2016, MMI operates 81 offices in the United States and Canada through its wholly-owned subsidiary, Marcus & Millichap Real Estate Investment Services, Inc. (“MMREIS”), which includes the operations of Marcus & Millichap Capital Corporation (“MMCC”). |
Reorganization and Initial Public Offering | Reorganization and Initial Public Offering MMI was formed in June 2013 in preparation for Marcus & Millichap Company (“MMC”) to spin-off its majority owned subsidiary, MMREIS (“Spin-Off”). Prior to the initial public offering (“IPO”) of MMI, all of the preferred and common stockholders of MMREIS (including MMC and employees of MMREIS) contributed all of their outstanding shares to MMI in exchange for new MMI common stock. As a result, MMREIS became a wholly-owned subsidiary of MMI. Thereafter, MMC distributed 80.0% of the shares of MMI common stock to MMC’s shareholders and exchanged the remaining portion of its shares of MMI common stock for cancellation of indebtedness of MMC. MMI completed its IPO on October 30, 2013. |
Basis of Presentation | Basis of Presentation The financial information presented in the accompanying unaudited condensed consolidated financial statements, has been prepared in accordance with rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for quarterly reports on Form 10-Q and Article 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. generally accepted accounting principles (“U.S. GAAP”) for complete financial statements. In the opinion of management, the accompanying unaudited condensed consolidated financial statements and notes include all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation of the consolidated financial position, results of operations and cash flows for the periods presented. These unaudited condensed consolidated financial statements should be read in conjunction with the annual audited consolidated financial statements and notes thereto for the year ended December 31, 2015 included in the Company’s Annual Report on Form 10-K filed on March 15, 2016 with the SEC. The results of the three and six months ended June 30, 2016 are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2016, or for other interim periods or future years. |
Consolidation | Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. |
Use of Estimates | Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosures at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. |
Reclassifications | Reclassifications Certain prior-period amounts have been reclassified to conform to the current period presentation. These changes had no impact on the previously reported condensed consolidated results of operations, financial condition, stockholders’ equity or on cash flows subtotals. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to a concentration of credit risk principally consist of cash and cash equivalents, due from independent contractors (included under other assets, net current and other assets non-current captions), investments in marketable securities, available-for-sale, security deposits (included under other assets, non-current caption) and commissions receivables. Cash is placed with high-credit quality financial institutions and invested high-credit quality money market funds. To reduce its credit risk, the Company monitors the credit standing of the financial institutions that hold the Company’s cash and cash equivalents. The Company historically has not experienced any losses related to cash and cash equivalents. The Company derives its revenues from a broad range of real estate investors, owners and users in the United States and Canada, none of which individually represents a significant concentration of credit risk. The Company performs credit evaluations of its customers and debtors and requires collateral on a case-by-case basis. The Company maintains allowances, as needed, for estimated credit losses based on management’s assessment of the likelihood of collection. For the three and six months ended June 30, 2016 and 2015, no transaction represented 10% or more of total revenues. Further, while one or more transactions may represent 10% or more of commissions receivable at any reporting date, amounts due are typically collected within 10 days of settlement and therefore do not expose the Company to significant credit risk. The Company’s Canadian operations represented less than 1.0% of total revenues in each period presented. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date Revenue from Contacts with Customers: Principal Versus Agent Considerations Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing Revenue from Contracts with Customers: Narrow-Scope Improvements and Practical Expedients ASU 2014-09 permits two implementation approaches, one requiring retrospective application of the new standard with restatement of prior years and one requiring prospective application of the new standard with disclosure of results under old standards. For the Company, the new standard will be effective January 1, 2018. The Company does not have multiple-element arrangements, variable consideration, licenses and long-term contracts with customers. Accordingly, the Company does not expect this standard to have a significant effect in the manner or timing of its revenue recognition. The Company is in the process of completing the evaluation of the impact of this new standard and will select a transition method when the effect is determined. In August 2014, the FASB issued ASU No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern In February 2016, the FASB issued ASU No. 2016-02, Leases In March 2016, the FASB issued ASU No. 2016-09, Improvements to Employee Share-Based Payment Accounting 1. Accounting for income taxes upon vesting or settlement of awards 2. Presentation of excess tax benefits on the statement of cash flows 3. Accounting for forfeitures 4. Minimum statutory withholding requirements 5. Presentation of employee taxes paid on the statement of cash flows when an employer withholds shares to meet minimum statutory withholding requirements 6. Private company practical expedients ASU 2016-09 is effective for reporting periods beginning after December 15, 2016 and early adoption is permitted. For the Company, the new standard will be effective January 1, 2017. The Company is currently evaluating the impact of ASU 2016-09 and timeframe for adoption. Since the Company issues stock-based awards to its employees and independent contractors and has recognized windfall tax benefits in additional paid in capital, it is anticipated that the ASU, when adopted, will impact (i) the Company’s provision for income taxes, and therefore net and comprehensive income and related earnings per share amounts, (ii) amounts presented in the condensed consolidated statement of stockholders’ equity and condensed consolidated statements of cash flows and (iii) to a lesser extent the timing of our stock-based compensation expense. See Note 9 – “Stock-Based Compensation Plans” for additional information. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses |
Leases | The Company leases all of its facilities under operating lease agreements. Lease agreements may contain periods of free rent or reduced rent or contain predetermined fixed increases in the minimum rent. The Company recognizes the minimum lease payments as rent expense on a straight-line basis over the noncancellable term of the lease. The Company records the difference between the amount charged to rent expense and the rent paid as a deferred rent obligation. The Company typically leases general purpose built-out office space, which reverts to the lessor upon termination of the lease. Any payments for improvements, net of incentives received, are recorded as prepaid rent. Prepaid rent is amortized using the straight-line method over the expected lease term as a charge to rent expense. |
Investments in Marketable Securities | The Company considers the declines in market value of its marketable securities, available-for-sale to be temporary in nature and does not consider any of its investments other-than-temporarily impaired. The Company typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy generally requires investments to be investment grade, with the primary objective of minimizing the potential risk of principal loss and matching long-term liabilities. When evaluating an investment for other-than-temporary impairment the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates and the Company’s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment’s cost basis. |
Fair Value Measurements | U.S. GAAP defines the fair value of a financial instrument as the amount that would be received from the sale of an asset in an orderly transaction between market participants at the measurement date. The Company is responsible for the determination of the value of the investment carried and fair value and the supporting methodologies and assumptions. The Company uses various pricing sources to validate the values utilized. The degree of judgment used in measuring the fair value of financial instruments is generally inversely correlates with the level of observable valuation inputs. Financial instruments with quoted prices in active markets generally have more pricing observability and less judgment is used in measuring fair value. Financial instruments for which no quoted prices are available have less observability and are measured at fair value using valuation models or other pricing techniques that require more judgment. Assets recorded at fair value are measured and classified in accordance with a fair value hierarchy consisting of the three “levels” based on the observability of inputs available in the marketplace used to measure the fair values as discussed below: Level 1: Level 2: Level 3: |
Stock Based Compensation Plans | The Company grants RSUs to independent contractors (i.e. investment sales and financing professionals), who are considered non-employees under ASC 718. Accordingly, such awards are required to be measured at fair value at the end of each reporting period until settlement. Stock-based compensation expense is therefore impacted by the changes in the Company’s common stock price during each reporting period. |
Income Taxes | The Company provides for the effects of income taxes in interim financial statements based on the Company’s estimate of its annual effective tax rate for the full year, which is based on forecasted income by jurisdiction where the Company operates, adjusted for the tax effects of items that relate discretely to the period, if any. The difference between the statutory tax rate and the Company’s effective tax rate is largely attributable to state income taxes and a full valuation allowance with respect to the deferred tax assets of the Company’s Canadian operations. |
Property and Equipment (Tables)
Property and Equipment (Tables) | 6 Months Ended |
Jun. 30, 2016 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property and Equipment, Net | Property and equipment, net consist of the following (in thousands): June 30, December 31, Computer software and hardware equipment $ 12,399 $ 10,973 Furniture, fixtures, and equipment 19,109 17,047 Less: accumulated depreciation and amortization (17,205 ) (16,441 ) $ 14,303 $ 11,579 |
Selected Balance Sheet Data (Ta
Selected Balance Sheet Data (Tables) | 6 Months Ended |
Jun. 30, 2016 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Schedule of Other Assets | Other assets consisted of the following (in thousands): Current Non-Current June 30, December 31, June 30, December 31, 2016 2015 2016 2015 Due from independent contractors, net (1) (2) $ 1,857 $ 2,545 $ 8,142 $ 7,358 Security deposits — — 1,073 1,425 Employee notes receivable (3) 364 224 112 158 Customer trust accounts and other 2,717 2,367 330 175 $ 4,938 $ 5,136 $ 9,657 $ 9,116 (1) Represents amounts advanced, notes receivable and other receivables due from the Company’s investment sales and financing professionals. The notes receivable along with interest, are typically collected from future commissions and are generally due in one to five years. (2) Includes allowance for doubtful accounts related to current receivables of $297 and $359 as of June 30, 2016 and December 31, 2015, respectively. The Company recorded a (recovery) provision for bad debt expense of $(13) and $58 and wrote off $11 and $29 of these receivables for the three months ended June 30, 2016 and 2015, respectively. The Company recorded a provision for bad debt expense of $3 and $79 and wrote off $65 and $35 of these receivables for the six months ended June 30, 2016 and 2015, respectively. (3) See Note 6 – “Related-Party Transactions” for additional information. |
Components of Deferred Compensation and Commissions | Deferred compensation and commissions consisted of the following (in thousands): June 30, December 31, SARs liability $ 21,856 $ 21,399 Commissions payable to investment sales and financing professionals 10,010 17,015 Deferred compensation liability 6,714 5,264 $ 38,580 $ 43,678 |
Summary of Net Change in Carrying Value of Assets Held in Rabbi Trust and Deferred Compensation Liability | The net change in the carrying value of the assets held in the rabbi trust and the net change in the carrying value of the deferred compensation liability, each exclusive of additional contributions, distributions and trust expenses consisted of the following (in thousands): Three Months Ended Six Months Ended June 30, 2016 2015 2016 2015 Increase (decrease) in the carrying value of the assets held in the rabbi trust (1) $ 150 $ (104 ) $ 184 $ 11 Increase (decrease) in the carrying value of the deferred compensation (2) $ 151 $ (94 ) $ 188 $ 59 (1) Recorded in other income (expense), net in the condensed consolidated statements of net and comprehensive income. (2) Recorded in selling, general and administrative expense in the condensed consolidated statements of net and comprehensive income. |
Investments in Marketable Sec23
Investments in Marketable Securities (Tables) | 6 Months Ended |
Jun. 30, 2016 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of Amortized Cost and Fair Value of Marketable Securities, Available-for-Sale, by Type of Security | Amortized cost and fair value of marketable securities, available-for-sale, by type of security consisted of the following (in thousands): June 30, 2016 December 31, 2015 Amortized Gross Gross Fair Value Amortized Gross Gross Fair Value Short-term investments: U.S. Treasuries $ 53,278 $ 35 $ — $ 53,313 $ 62,343 $ — $ (71 ) $ 62,272 U.S. Government Sponsored Entities 8,509 7 — 8,516 17,571 — (12 ) 17,559 Corporate debt securities 19,939 7 — 19,946 29 — — 29 $ 81,726 $ 49 $ — $ 81,775 $ 79,943 $ — $ (83 ) $ 79,860 Long-term investments: U.S. Treasuries $ 21,176 $ 250 $ — $ 21,426 $ 15,283 $ — $ (112 ) $ 15,171 U.S. Government Sponsored Entities 15,919 48 — 15,967 12,107 — (85 ) 12,022 Corporate debt securities 16,412 503 (39 ) 16,876 17,219 5 (519 ) 16,705 Asset-backed securities and other 9,839 128 (58 ) 9,909 10,649 — (152 ) 10,497 $ 63,346 $ 929 $ (97 ) $ 64,178 $ 55,258 $ 5 $ (868 ) $ 54,395 |
Amortized Cost and Fair Value of Investments in Available for Sale Securities | The amortized cost and fair value of the Company’s investments in available-for-sale securities that have been in a continuous unrealized loss position consisted of the following (in thousands): June 30, 2016 December 31, 2015 Unrealized Fair Value Unrealized Fair Value Less than 12 months $ (72 ) $ 4,607 $ (951 ) $ 129,117 12 months or longer $ (25 ) $ 1,879 $ — $ — |
Gross Realized Gains and Losses from Sale of Available for Sale Securities | Gross realized gains and gross realized losses from the sales of the Company’s available-for-sale securities consisted of the following (in thousands): Three Months Ended Six Months Ended 2016 2015 2016 2015 Gross realized gain (1) $ 20 $ 56 $ 20 $ 133 Gross realized loss (1) $ — $ — $ (155 ) $ (3 ) (1) Recorded in other income (expense), net in the condensed consolidated statements of net and comprehensive income. The cost basis of securities sold were determined on the specific identification method. |
Schedule of Amortized Cost and Fair Value of Marketable Securities, Available-for-Sale, by Contractual Maturity | Amortized cost and fair value of marketable securities, available-for-sale, by contractual maturity consisted of the following (in thousands): June 30, 2016 December 31, 2015 Amortized Fair Value Amortized Fair Value Due in one year or less $ 81,726 $ 81,775 $ 79,943 $ 79,860 Due after one year through five years 40,259 40,473 28,634 28,465 Due after five years through ten years 15,002 15,529 18,020 17,466 Due after ten years 8,085 8,176 8,604 8,464 $ 145,072 $ 145,953 $ 135,201 $ 134,255 Weighted average contractual maturity 3.0 years 3.3 years |
Notes Payable to Former Stock24
Notes Payable to Former Stockholders (Tables) | 6 Months Ended |
Jun. 30, 2016 | |
Payables and Accruals [Abstract] | |
Schedule of Accrued Interest Pertaining to Notes | Accrued interest pertaining to the Notes consisted of the following (in thousands): June 30, 2016 December 31, Accrued interest (1) $ 94 $ 367 (1) Recorded in accounts payable and accrued expenses in the accompanying condensed consolidated balance sheets. |
Schedule of Interest Expense Pertaining to Notes | Interest expense pertaining to the Notes consisted of the following (in thousands): Three Months Ended Six Months Ended 2016 2015 2016 2015 Interest expense $ 126 $ 137 $ 259 $ 281 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 6 Months Ended |
Jun. 30, 2016 | |
Fair Value Disclosures [Abstract] | |
Schedule of Investments at Fair Value on Recurring Basis | Investments carried at fair value are categorized into one of the three categories described above and consisted of the following (in thousands): June 30, 2016 December 31, 2015 Fair Level 1 Level 2 Level 3 Fair Level 1 Level 2 Level 3 Assets held in rabbi trust $ 7,106 $ — $ 7,106 $ — $ 5,661 $ — $ 5,661 $ — Money market funds (1) $ 56,802 $ 56,802 $ — $ — $ 5,987 $ 5,987 $ — $ — Marketable securities, available-for-sale: Short-term investments: U.S. Treasuries $ 53,313 $ 53,313 $ — $ — $ 62,272 $ 62,272 $ — $ — U.S. Government Sponsored Entities 8,516 — 8,516 — 17,559 — 17,559 — Corporate debt securities 19,946 — 19,946 — 29 — 29 — $ 81,775 $ 53,313 $ 28,462 $ — $ 79,860 $ 62,272 $ 17,588 $ — Long-term investments: U.S. Treasuries $ 21,426 $ 21,426 $ — $ — $ 15,171 $ 15,171 $ — $ — U.S. Government Sponsored Entities 15,967 — 15,967 — 12,022 — 12,022 — Corporate debt securities 16,876 — 16,876 — 16,705 — 16,705 — Asset-backed securities and other 9,909 — 9,909 — 10,497 — 10,497 — $ 64,178 $ 21,426 $ 42,752 $ — $ 54,395 $ 15,171 $ 39,224 $ — (1) Included in cash and cash equivalents. |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 6 Months Ended |
Jun. 30, 2016 | |
Equity [Abstract] | |
Changes in Accumulated Other Comprehensive Income, Net of Income Taxes | The components of accumulated other comprehensive income as of June 30, 2016, by component, net of income taxes consisted of the following (in thousands): Unrealized available-for- Foreign (2) Total Beginning balance, December 31, 2015 $ (568 ) $ 1,025 $ 457 Other comprehensive income before reclassifications 1,200 35 1,235 Amounts reclassified from accumulated other comprehensive income (1) (94 ) — (94 ) Net current-period other comprehensive income 1,106 35 1,141 Ending balance, June 30, 2016 $ 538 $ 1,060 $ 1,598 (1) Included as a component of other income (expense), net in the condensed consolidated statements of net and comprehensive income. The reclassifications were determined on a specific identification basis. (2) The Company has not provided for U.S. taxes on unremitted earnings of its foreign subsidiary as it is operating at a loss and has no earnings and profits to remit. As a result, deferred taxes were not provided related to the cumulative foreign currency translation adjustments. |
Stock-Based Compensation Plans
Stock-Based Compensation Plans (Tables) | 6 Months Ended |
Jun. 30, 2016 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Outstanding Awards Under 2013 Omnibus Equity Incentive Plan | Activity under the 2013 Plan consisted of the following (dollars in thousands, except per share data): RSA Grants to RSU Grants to RSU Grants to Total Weighted- Nonvested shares at December 31, 2015 35,364 468,969 521,780 1,026,113 $ 21.17 Granted February 2016 — 172,496 8,856 181,352 March 2016 — 30,000 — 30,000 May 2016 14,742 11,051 8,188 33,981 Total Granted 14,742 213,547 17,044 245,333 23.18 Vested (10,998 ) (101,040 ) (117,866 ) (229,904 ) 19.13 Transferred — — — — — Forfeited/canceled — (6,974 ) (4,135 ) (11,109 ) 21.50 Nonvested shares at June 30, (1) 39,108 574,502 416,823 1,030,433 $ 22.11 Unrecognized stock-based compensation expense as of June 30, 2016 (2) $ 705 $ 11,897 $ 8,556 $ 21,158 Weighted average remaining vesting period (years) as of June 30, 2016 2.09 3.81 2.80 3.35 (1) Nonvested RSU’s will be settled through the issuance of new shares of common stock. (2) The total unrecognized compensation expense is expected to be recognized over a weighted-average period of approximately 3.35 years. |
Stock-Based Compensation Expense | Components of stock-based compensation included in selling, general and administrative expense in the condensed consolidated statements of net and comprehensive income consisted of the following (in thousands, except common stock price): Three Months Ended June 30, Six Months Ended June 30, 2016 2015 2016 2015 Employee stock purchase plan $ 60 $ 66 $ 108 $ 128 RSAs – non-employee directors 109 78 198 137 RSUs – employees 818 552 1,476 1,079 RSUs – independent contractors (1) 788 1,979 1,318 3,238 $ 1,775 $ 2,675 $ 3,100 $ 4,582 Common stock price at beginning of period $ 25.39 $ 37.48 $ 29.14 $ 33.25 Common stock price at end of period $ 25.41 $ 46.14 $ 25.41 $ 46.14 Increase (decrease) in stock price $ 0.02 $ 8.66 $ (3.73 ) $ 12.89 (1) The Company grants RSUs to independent contractors (i.e. investment sales and financing professionals), who are considered non-employees under ASC 718. Accordingly, such awards are required to be measured at fair value at the end of each reporting period until settlement. Stock-based compensation expense is therefore impacted by the changes in the Company’s common stock price during each reporting period. |
Earnings per Share (Tables)
Earnings per Share (Tables) | 6 Months Ended |
Jun. 30, 2016 | |
Earnings Per Share [Abstract] | |
Computation of Basic and Diluted Earnings Per Share, Including Antidilutive Securities Excluded from Computation of Earnings Per Share | The following table sets forth the computation of basic and diluted earnings per share for the three and six months ended June 30, 2016 and 2015, respectively (in thousands, except per share data): Three Months Ended June 30, Six Months Ended June 30, 2016 2015 2016 2015 Numerator (Basic and Diluted): Net income $ 17,524 $ 17,556 $ 32,339 $ 31,225 Denominator: Basic Weighted average common shares issued and outstanding 37,591 37,092 37,576 37,080 Deduct: Unvested RSAs (1) (38 ) (44 ) (36 ) (44 ) Add: Fully vested DSUs (2) 1,365 1,822 1,365 1,822 Weighted Average Common Shares Outstanding 38,918 38,870 38,905 38,858 Basic earnings per common share $ 0.45 $ 0.45 $ 0.83 $ 0.80 Diluted Weighted Average Common Shares Outstanding from above 38,918 38,870 38,905 38,858 Add: Dilutive effect of RSUs, RSAs & ESPP 136 187 103 148 Weighted Average Common Shares Outstanding 39,054 39,057 39,008 39,006 Diluted earnings per common share $ 0.45 $ 0.45 $ 0.83 $ 0.80 Antidilutive shares excluded from diluted earnings per common share (3) 244 59 449 535 (1) RSAs were issued and outstanding to the non-employee directors and have a three year vesting term subject to service requirements. See Note 9 – “Stock-Based Compensation Plans” for additional information. (2) Shares are included in weighted average common shares outstanding as the shares are fully vested but have not yet been delivered. See Note 8 – “Stockholders’ Equity” for additional information. (3) Primarily pertaining to RSU grants to the Company’s independent contractors. |
Description of Business, Basi29
Description of Business, Basis of Presentation and Recent Accounting Pronouncements - Additional Information (Detail) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2016USD ($) | Jun. 30, 2015 | Jun. 30, 2016USD ($)Office | Jun. 30, 2015 | |
Class of Stock [Line Items] | ||||
Number of offices in the United States and Canada | Office | 81 | |||
Formation date | 2013-06 | |||
Percentage of common stock distributed | 80.00% | |||
IPO completion date | Oct. 30, 2013 | |||
Commission's receivable settled period | 10 days | |||
Operating lease obligations | $ | $ 80.3 | $ 80.3 | ||
Customer Concentration Risk [Member] | Total revenues [Member] | ||||
Class of Stock [Line Items] | ||||
Concentration of credit risk percentage | 10.00% | 10.00% | 10.00% | 10.00% |
Customer Concentration Risk [Member] | Commissions receivable [Member] | ||||
Class of Stock [Line Items] | ||||
Concentration of credit risk percentage | 10.00% | 10.00% | 10.00% | 10.00% |
Geographic Concentration Risk [Member] | Total revenues [Member] | Maximum [Member] | CANADA | ||||
Class of Stock [Line Items] | ||||
Concentration of credit risk percentage | 1.00% |
Property and Equipment - Schedu
Property and Equipment - Schedule of Property and Equipment, Net (Detail) - USD ($) $ in Thousands | Jun. 30, 2016 | Dec. 31, 2015 |
Property, Plant and Equipment [Line Items] | ||
Less: accumulated depreciation and amortization | $ (17,205) | $ (16,441) |
Property and equipment, net | 14,303 | 11,579 |
Computer software and hardware equipment [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment | 12,399 | 10,973 |
Furniture, fixtures, and equipment [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment | $ 19,109 | $ 17,047 |
Property and Equipment - Additi
Property and Equipment - Additional Information (Detail) - USD ($) $ in Millions | 6 Months Ended | |
Jun. 30, 2016 | Jun. 30, 2015 | |
Property, Plant and Equipment [Abstract] | ||
Fully depreciated computer software and hardware and furniture, fixtures and equipment write-off | $ 1.5 | $ 2 |
Selected Balance Sheet Data - S
Selected Balance Sheet Data - Schedule of Other Assets (Detail) - USD ($) $ in Thousands | Jun. 30, 2016 | Dec. 31, 2015 |
Other Assets [Line Items] | ||
Other assets Current | $ 4,938 | $ 5,136 |
Other assets Non-Current | 9,657 | 9,116 |
Due from independent contractors [Member] | ||
Other Assets [Line Items] | ||
Other assets Current | 1,857 | 2,545 |
Other assets Non-Current | 8,142 | 7,358 |
Security deposits [Member] | ||
Other Assets [Line Items] | ||
Other assets Current | 0 | 0 |
Other assets Non-Current | 1,073 | 1,425 |
Employee Notes Receivable [Member] | ||
Other Assets [Line Items] | ||
Other assets Current | 364 | 224 |
Other assets Non-Current | 112 | 158 |
Customer trust accounts and other [Member] | ||
Other Assets [Line Items] | ||
Other assets Current | 2,717 | 2,367 |
Other assets Non-Current | $ 330 | $ 175 |
Selected Balance Sheet Data -33
Selected Balance Sheet Data - Schedule of Other Assets (Parenthetical) (Detail) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2016 | Jun. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2015 | Dec. 31, 2015 | |
Other Assets [Line Items] | |||||
Allowance of doubtful accounts | $ 297 | $ 297 | $ 359 | ||
Provision (recovery) for bad debt expense | (13) | $ 58 | 3 | $ 79 | |
Write-off receivables | $ 11 | $ 29 | $ 65 | $ 35 | |
Minimum [Member] | |||||
Other Assets [Line Items] | |||||
Notes receivable due period | 1 year | ||||
Maximum [Member] | |||||
Other Assets [Line Items] | |||||
Notes receivable due period | 5 years |
Selected Balance Sheet Data - C
Selected Balance Sheet Data - Components of Deferred Compensation and Commissions (Detail) - USD ($) $ in Thousands | Jun. 30, 2016 | Dec. 31, 2015 |
Balance Sheet Related Disclosures [Abstract] | ||
SARs liability | $ 21,856 | $ 21,399 |
Commissions payable to investment sales and financing professionals | 10,010 | 17,015 |
Deferred compensation liability | 6,714 | 5,264 |
Total | $ 38,580 | $ 43,678 |
Selected Balance Sheet Data - A
Selected Balance Sheet Data - Additional Information (Detail) - USD ($) | Jan. 01, 2016 | Jan. 01, 2015 | Jan. 01, 2014 | Jun. 30, 2016 | Jun. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2015 | Dec. 31, 2015 | Mar. 31, 2013 |
Schedule Of Accrued Expenses [Line Items] | |||||||||
SARs frozen liability amount | $ 21,856,000 | $ 21,856,000 | $ 21,399,000 | ||||||
Interest expense | 384,000 | $ 386,000 | $ 775,000 | $ 969,000 | |||||
Maximum payment deferral period for certain commissions payable | 3 years | ||||||||
Fair value of deferred compensation plan assets | 110.00% | ||||||||
SARs [Member] | |||||||||
Schedule Of Accrued Expenses [Line Items] | |||||||||
SARs frozen liability amount | $ 20,000,000 | ||||||||
SARs liability frozen value date | Mar. 31, 2013 | ||||||||
SARs liability interest accrual commencement date | Jan. 1, 2014 | ||||||||
Interest expense | $ 228,000 | $ 214,000 | $ 457,000 | $ 428,000 | |||||
Treasury note term | 10 years | ||||||||
Base spread on SARs liability variable rate | 2.00% | ||||||||
SARs liability interest accrual rates | 4.273% | 4.173% |
Selected Balance Sheet Data -36
Selected Balance Sheet Data - Summary of Net Change in Carrying Value of Assets Held in Rabbi Trust and Deferred Compensation Liability (Detail) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2016 | Jun. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2015 | |
Balance Sheet Related Disclosures [Abstract] | ||||
Increase (decrease) in the carrying value of the assets held in the rabbi trust | $ 150 | $ (104) | $ 184 | $ 11 |
Increase (decrease) in the carrying value of the deferred compensation obligation | $ 151 | $ (94) | $ 188 | $ 59 |
Investments in Marketable Sec37
Investments in Marketable Securities - Schedule of Amortized Cost and Fair Value of Marketable Securities, Available-for-Sale, by Type of Security (Detail) - USD ($) $ in Thousands | Jun. 30, 2016 | Dec. 31, 2015 |
Schedule of Available-for-sale Securities [Line Items] | ||
Amortized Cost | $ 145,072 | $ 135,201 |
Fair Value | 145,953 | 134,255 |
Short-term investments [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Amortized Cost | 81,726 | 79,943 |
Gross Unrealized Gains | 49 | 0 |
Gross Unrealized Losses | 0 | (83) |
Fair Value | 81,775 | 79,860 |
Short-term investments [Member] | U.S. Treasuries [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Amortized Cost | 53,278 | 62,343 |
Gross Unrealized Gains | 35 | 0 |
Gross Unrealized Losses | 0 | (71) |
Fair Value | 53,313 | 62,272 |
Short-term investments [Member] | U.S. Government Sponsored Entities [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Amortized Cost | 8,509 | 17,571 |
Gross Unrealized Gains | 7 | 0 |
Gross Unrealized Losses | 0 | (12) |
Fair Value | 8,516 | 17,559 |
Short-term investments [Member] | Corporate debt securities [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Amortized Cost | 19,939 | 29 |
Gross Unrealized Gains | 7 | 0 |
Gross Unrealized Losses | 0 | 0 |
Fair Value | 19,946 | 29 |
Long-term marketable securities [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Amortized Cost | 63,346 | 55,258 |
Gross Unrealized Gains | 929 | 5 |
Gross Unrealized Losses | (97) | (868) |
Fair Value | 64,178 | 54,395 |
Long-term marketable securities [Member] | U.S. Treasuries [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Amortized Cost | 21,176 | 15,283 |
Gross Unrealized Gains | 250 | 0 |
Gross Unrealized Losses | 0 | (112) |
Fair Value | 21,426 | 15,171 |
Long-term marketable securities [Member] | U.S. Government Sponsored Entities [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Amortized Cost | 15,919 | 12,107 |
Gross Unrealized Gains | 48 | 0 |
Gross Unrealized Losses | 0 | (85) |
Fair Value | 15,967 | 12,022 |
Long-term marketable securities [Member] | Corporate debt securities [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Amortized Cost | 16,412 | 17,219 |
Gross Unrealized Gains | 503 | 5 |
Gross Unrealized Losses | (39) | (519) |
Fair Value | 16,876 | 16,705 |
Long-term marketable securities [Member] | Asset-backed securities and other [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Amortized Cost | 9,839 | 10,649 |
Gross Unrealized Gains | 128 | 0 |
Gross Unrealized Losses | (58) | (152) |
Fair Value | $ 9,909 | $ 10,497 |
Investments in Marketable Sec38
Investments in Marketable Securities - Amortized Cost and Fair Value of Investments in Available for Sale Securities (Detail) - USD ($) $ in Thousands | Jun. 30, 2016 | Dec. 31, 2015 |
Available-for-sale Securities, Continuous Unrealized Loss Position [Abstract] | ||
Available for sale securities continuous unrealized loss position for less than 12 months, unrealized loss | $ (72) | $ (951) |
Available for sale securities continuous unrealized loss position for 12 months or longer, unrealized loss | (25) | 0 |
Available for sale securities continuous unrealized loss position for less than 12 months, fair value | 4,607 | 129,117 |
Available for sale securities continuous unrealized loss position for 12 months or longer, fair value | $ 1,879 | $ 0 |
Investments in Marketable Sec39
Investments in Marketable Securities - Gross Realized Gains and Losses from Sale of Available for Sale Securities (Detail) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2016 | Jun. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2015 | |
Available-for-sale Securities, Gross Realized Gain (Loss) [Abstract] | ||||
Gross realized gain | $ 20 | $ 56 | $ 20 | $ 133 |
Gross realized loss | $ 0 | $ 0 | $ (155) | $ (3) |
Investments in Marketable Sec40
Investments in Marketable Securities - Additional Information (Detail) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2016 | Jun. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2015 | |
Schedule of Available-for-sale Securities [Line Items] | ||||
Gross realized loss | $ 0 | $ 0 | $ 155,000 | $ 3,000 |
Sale of Available-For-Sale, Marketable Security that No Longer Met Investment Policy [Member] | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Gross realized loss | $ 152,000 |
Investments in Marketable Sec41
Investments in Marketable Securities - Schedule of Amortized Cost and Fair Value of Marketable Securities, Available-for-Sale, by Contractual Maturity (Detail) - USD ($) $ in Thousands | 6 Months Ended | 12 Months Ended |
Jun. 30, 2016 | Dec. 31, 2015 | |
Investments, Debt and Equity Securities [Abstract] | ||
Due in one year or less, Amortized Cost | $ 81,726 | $ 79,943 |
Due after one year through five years, Amortized Cost | 40,259 | 28,634 |
Due after five years through ten years, Amortized Cost | 15,002 | 18,020 |
Due after ten years, Amortized Cost | 8,085 | 8,604 |
Amortized Cost | 145,072 | 135,201 |
Due in one year or less, Fair Value | 81,775 | 79,860 |
Due after one year through five years, Fair Value | 40,473 | 28,465 |
Due after five years through ten years, Fair Value | 15,529 | 17,466 |
Due after ten years, Fair Value | 8,176 | 8,464 |
Total Fair Value | $ 145,953 | $ 134,255 |
Weighted average contractual maturity | 3 years | 3 years 3 months 18 days |
Notes Payable to Former Stock42
Notes Payable to Former Stockholders - Additional Information (Detail) - USD ($) $ in Millions | 6 Months Ended | |
Jun. 30, 2016 | Jun. 30, 2015 | |
Notes Payable to Former Stockholders [Member] | ||
Debt Instrument [Line Items] | ||
Principal and interest payments on notes payable to former stockholders | $ 1.5 | $ 1.5 |
Restricted Stock - Notes Payable [Member] | ||
Debt Instrument [Line Items] | ||
Unsecured notes interest rate | 5.00% | |
Unsecured notes maturity date | Jun. 30, 2020 | |
SARs - Notes Payable [Member] | ||
Debt Instrument [Line Items] | ||
Unsecured notes interest rate | 5.00% | |
Unsecured notes maturity date | Jun. 30, 2020 |
Notes Payable to Former Stock43
Notes Payable to Former Stockholders - Schedule of Accrued Interest Pertaining to Notes (Detail) - USD ($) $ in Thousands | Jun. 30, 2016 | Dec. 31, 2015 |
Accounts Payable and Accrued Expenses [Member] | ||
Accounts Payable And Accrued Expenses [Line Items] | ||
Accrued interest | $ 94 | $ 367 |
Notes Payable to Former Stock44
Notes Payable to Former Stockholders - Schedule of Interest Expense Pertaining to Notes (Detail) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2016 | Jun. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2015 | |
Interest Expense [Line Items] | ||||
Interest expense | $ 384 | $ 386 | $ 775 | $ 969 |
Notes Payable to Former Stockholders [Member] | ||||
Interest Expense [Line Items] | ||||
Interest expense | $ 126 | $ 137 | $ 259 | $ 281 |
Related-Party Transactions - Ad
Related-Party Transactions - Additional Information (Detail) - USD ($) | Jun. 30, 2016 | Jun. 30, 2016 | Jun. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2015 | Dec. 31, 2015 |
Related Party Transaction [Line Items] | ||||||
Transition services agreement date | Oct. 1, 2013 | |||||
Real estate brokerage commissions and financing fees from transactions with former parent, Marcus & Millichap Company | $ 793,000 | $ 238,000 | $ 2,400,000 | $ 1,300,000 | ||
Commission expenses for transactions with former parent, Marcus & Millichap Company | 476,000 | 143,000 | 1,400,000 | 770,000 | ||
Aggregate principal amount outstanding for employee notes receivable | $ 476,000 | 476,000 | 476,000 | $ 382,000 | ||
MMC [Member] | ||||||
Related Party Transaction [Line Items] | ||||||
Rent expense for lease | $ 253,000 | 146,000 | 506,000 | 255,500 | ||
Lease expiration date | May 31, 2022 | |||||
MMC [Member] | Transition Services Agreement [Member] | ||||||
Related Party Transaction [Line Items] | ||||||
Selling, general and administrative expense | $ 54,000 | $ 59,000 | 124,000 | $ 109,000 | ||
Accounts payable and other accrued expenses - related party | $ 103,000 | $ 103,000 | $ 103,000 | $ 96,000 | ||
George M. Marcus [Member] | ||||||
Related Party Transaction [Line Items] | ||||||
Beneficial ownership percentage | 55.20% |
Fair Value Measurements - Sched
Fair Value Measurements - Schedule of Investments at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands | Jun. 30, 2016 | Dec. 31, 2015 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets held in rabbi trust | $ 7,106 | $ 5,661 |
Marketable securities, available for sale | 145,953 | 134,255 |
Short-term investments [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 81,775 | 79,860 |
Short-term investments [Member] | U.S. Treasuries [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 53,313 | 62,272 |
Short-term investments [Member] | U.S. Government Sponsored Entities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 8,516 | 17,559 |
Short-term investments [Member] | Corporate debt securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 19,946 | 29 |
Long-term marketable securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 64,178 | 54,395 |
Long-term marketable securities [Member] | U.S. Treasuries [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 21,426 | 15,171 |
Long-term marketable securities [Member] | U.S. Government Sponsored Entities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 15,967 | 12,022 |
Long-term marketable securities [Member] | Corporate debt securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 16,876 | 16,705 |
Long-term marketable securities [Member] | Asset-backed securities and other [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 9,909 | 10,497 |
Recurring [Member] | Money market funds [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money market funds | 56,802 | 5,987 |
Recurring [Member] | Assets held in rabbi trust [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets held in rabbi trust | 7,106 | 5,661 |
Recurring [Member] | Short-term investments [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 81,775 | 79,860 |
Recurring [Member] | Short-term investments [Member] | U.S. Treasuries [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 53,313 | 62,272 |
Recurring [Member] | Short-term investments [Member] | U.S. Government Sponsored Entities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 8,516 | 17,559 |
Recurring [Member] | Short-term investments [Member] | Corporate debt securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 19,946 | 29 |
Recurring [Member] | Long-term marketable securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 64,178 | 54,395 |
Recurring [Member] | Long-term marketable securities [Member] | U.S. Treasuries [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 21,426 | 15,171 |
Recurring [Member] | Long-term marketable securities [Member] | U.S. Government Sponsored Entities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 15,967 | 12,022 |
Recurring [Member] | Long-term marketable securities [Member] | Corporate debt securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 16,876 | 16,705 |
Recurring [Member] | Long-term marketable securities [Member] | Asset-backed securities and other [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 9,909 | 10,497 |
Level 1 [Member] | Recurring [Member] | Money market funds [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money market funds | 56,802 | 5,987 |
Level 1 [Member] | Recurring [Member] | Assets held in rabbi trust [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets held in rabbi trust | 0 | 0 |
Level 1 [Member] | Recurring [Member] | Short-term investments [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 53,313 | 62,272 |
Level 1 [Member] | Recurring [Member] | Short-term investments [Member] | U.S. Treasuries [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 53,313 | 62,272 |
Level 1 [Member] | Recurring [Member] | Short-term investments [Member] | U.S. Government Sponsored Entities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 0 | 0 |
Level 1 [Member] | Recurring [Member] | Short-term investments [Member] | Corporate debt securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 0 | 0 |
Level 1 [Member] | Recurring [Member] | Long-term marketable securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 21,426 | 15,171 |
Level 1 [Member] | Recurring [Member] | Long-term marketable securities [Member] | U.S. Treasuries [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 21,426 | 15,171 |
Level 1 [Member] | Recurring [Member] | Long-term marketable securities [Member] | U.S. Government Sponsored Entities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 0 | 0 |
Level 1 [Member] | Recurring [Member] | Long-term marketable securities [Member] | Corporate debt securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 0 | 0 |
Level 1 [Member] | Recurring [Member] | Long-term marketable securities [Member] | Asset-backed securities and other [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 0 | 0 |
Level 2 [Member] | Recurring [Member] | Money market funds [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money market funds | 0 | 0 |
Level 2 [Member] | Recurring [Member] | Assets held in rabbi trust [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets held in rabbi trust | 7,106 | 5,661 |
Level 2 [Member] | Recurring [Member] | Short-term investments [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 28,462 | 17,588 |
Level 2 [Member] | Recurring [Member] | Short-term investments [Member] | U.S. Treasuries [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 0 | 0 |
Level 2 [Member] | Recurring [Member] | Short-term investments [Member] | U.S. Government Sponsored Entities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 8,516 | 17,559 |
Level 2 [Member] | Recurring [Member] | Short-term investments [Member] | Corporate debt securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 19,946 | 29 |
Level 2 [Member] | Recurring [Member] | Long-term marketable securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 42,752 | 39,224 |
Level 2 [Member] | Recurring [Member] | Long-term marketable securities [Member] | U.S. Treasuries [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 0 | 0 |
Level 2 [Member] | Recurring [Member] | Long-term marketable securities [Member] | U.S. Government Sponsored Entities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 15,967 | 12,022 |
Level 2 [Member] | Recurring [Member] | Long-term marketable securities [Member] | Corporate debt securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 16,876 | 16,705 |
Level 2 [Member] | Recurring [Member] | Long-term marketable securities [Member] | Asset-backed securities and other [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 9,909 | 10,497 |
Level 3 [Member] | Recurring [Member] | Money market funds [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money market funds | 0 | 0 |
Level 3 [Member] | Recurring [Member] | Assets held in rabbi trust [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets held in rabbi trust | 0 | 0 |
Level 3 [Member] | Recurring [Member] | Short-term investments [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 0 | 0 |
Level 3 [Member] | Recurring [Member] | Short-term investments [Member] | U.S. Treasuries [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 0 | 0 |
Level 3 [Member] | Recurring [Member] | Short-term investments [Member] | U.S. Government Sponsored Entities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 0 | 0 |
Level 3 [Member] | Recurring [Member] | Short-term investments [Member] | Corporate debt securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 0 | 0 |
Level 3 [Member] | Recurring [Member] | Long-term marketable securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 0 | 0 |
Level 3 [Member] | Recurring [Member] | Long-term marketable securities [Member] | U.S. Treasuries [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 0 | 0 |
Level 3 [Member] | Recurring [Member] | Long-term marketable securities [Member] | U.S. Government Sponsored Entities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 0 | 0 |
Level 3 [Member] | Recurring [Member] | Long-term marketable securities [Member] | Corporate debt securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | 0 | 0 |
Level 3 [Member] | Recurring [Member] | Long-term marketable securities [Member] | Asset-backed securities and other [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities, available for sale | $ 0 | $ 0 |
Fair Value Measurements - Addit
Fair Value Measurements - Additional Information (Detail) | Jun. 30, 2016USD ($) |
Fair Value Disclosures [Abstract] | |
Fair value, assets, level 1 to level 2 transfers, amount | $ 0 |
Fair value, assets, level 2 to level 1 transfers, amount | $ 0 |
Stockholders' Equity - Addition
Stockholders' Equity - Additional Information (Detail) - USD ($) | Jun. 30, 2016 | Dec. 31, 2015 |
Equity [Abstract] | ||
Common stock, shares issued | 37,607,636 | 37,396,456 |
Common stock, shares outstanding | 37,607,636 | 37,396,456 |
Common stock, par value | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized | 25,000,000 | 25,000,000 |
Preferred stock, par value | $ 0.0001 | $ 0.0001 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Undistributed earnings of foreign subsidiary | $ 0 |
Stockholders' Equity - Changes
Stockholders' Equity - Changes in Accumulated Other Comprehensive Income, Net of Income Taxes (Detail) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2016 | Jun. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2015 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Beginning balance | $ 457 | |||
Other comprehensive income before reclassifications | 1,235 | |||
Amounts reclassified from accumulated other comprehensive income | (94) | |||
Total other comprehensive income | $ 414 | $ (539) | 1,141 | $ (178) |
Ending balance | 1,598 | 1,598 | ||
Unrealized gains and (losses) of available-for-sale securities [Member] | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Beginning balance | (568) | |||
Other comprehensive income before reclassifications | 1,200 | |||
Amounts reclassified from accumulated other comprehensive income | (94) | |||
Total other comprehensive income | 1,106 | |||
Ending balance | 538 | 538 | ||
Foreign currency translation [Member] | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Beginning balance | 1,025 | |||
Other comprehensive income before reclassifications | 35 | |||
Amounts reclassified from accumulated other comprehensive income | 0 | |||
Total other comprehensive income | 35 | |||
Ending balance | $ 1,060 | $ 1,060 |
Stock-Based Compensation Plan50
Stock-Based Compensation Plans - 2013 Omnibus Equity Incentive Plan - Award Limitations - Additional Information (Detail) | 1 Months Ended | 6 Months Ended | |||
May 31, 2016shares | Mar. 31, 2016shares | Feb. 29, 2016shares | Nov. 30, 2013$ / sharesshares | Jun. 30, 2016Incentive_Planshares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Number of active equity plans | Incentive_Plan | 1 | ||||
Common stock shares reserved for issuance of awards | 5,500,000 | ||||
Common stock shares available for grant | 4,383,914 | ||||
Increase of common stock share reserve approved | 2,200,000 | ||||
Share-based awards granted during the period | 33,981 | 30,000 | 181,352 | 245,333 | |
Description of awards granted under the 2013 Plan | In November 2013, MMI issued the following equity awards under the 2013 Plan (i) Deferred stock units ("DSUs") for an aggregate of 2,192,413 shares granted as replacement awards related to the prior SARs program to the MMREIS managing directors and (ii) DSUs for 83,334 shares granted to the Company's Co-chairman of the board of directors, William A. Millichap. The DSU's are fully vested and shares will be issued ratably over 5 years | ||||
Common stock sold and issued under IPO, price per share | $ / shares | $ 12 | ||||
Deferred stock units [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Fully vested deferred stock units settlement period | 5 years | ||||
Deferred stock units [Member] | MMREIS Managing Directors [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Fully vested deferred stock units | 2,192,413 | ||||
Deferred stock units [Member] | Millichap [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Fully vested deferred stock units | 83,334 | ||||
Restricted Stock Awards [Member] | Non-Employee Directors [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Share-based awards granted during the period | 14,742 | 0 | 0 | 30,000 | 14,742 |
Vesting period | 3 years | 3 years |
Stock-Based Compensation Plan51
Stock-Based Compensation Plans - 2013 Omnibus Equity Incentive Plan - Additional Information (Detail) - USD ($) | 1 Months Ended | 6 Months Ended |
Nov. 30, 2013 | Jun. 30, 2016 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Number of common stock shares withheld to pay employee statutory withholding taxes | 40,408 | |
Windfall tax benefits net from stock-based award activity included in additional paid-in capital | $ 171,000 | |
Restricted Stock Awards [Member] | Non-Employee Directors [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Vesting period | 3 years | 3 years |
Restricted Stock Units (RSUs) [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Vesting period | 5 years | |
Deferred stock units [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Fully vested deferred stock units remaining outstanding | 1,365,445 |
Stock-Based Compensation Plan52
Stock-Based Compensation Plans - Outstanding Awards Under 2013 Omnibus Equity Incentive Plan (Detail) - USD ($) $ / shares in Units, $ in Thousands | 1 Months Ended | 6 Months Ended | |||
May 31, 2016 | Mar. 31, 2016 | Feb. 29, 2016 | Nov. 30, 2013 | Jun. 30, 2016 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Nonvested shares, beginning balance | 1,026,113 | ||||
Granted | 33,981 | 30,000 | 181,352 | 245,333 | |
Vested | (229,904) | ||||
Transferred | 0 | ||||
Forfeited/canceled | (11,109) | ||||
Nonvested shares, ending balance | 1,030,433 | ||||
Unrecognized stock-based compensation expense as of June 30, 2016 | $ 21,158 | ||||
Weighted average remaining vesting period (years) as of June 30, 2016 | 3 years 4 months 6 days | ||||
Nonvested weighted average grant date fair value per share, beginning balance | $ 21.17 | ||||
Weighted average grant date fair value per share, Granted | $ 0 | $ 0 | $ 0 | 23.18 | |
Weighted average grant date fair value, Vested | 19.13 | ||||
Weighted average grant date fair value, Transferred | 0 | ||||
Weighted average grant date fair value, Forfeited/canceled | 21.50 | ||||
Nonvested weighted average grant date fair value per share, ending balance | $ 22.11 | ||||
Restricted Stock Awards [Member] | Non-Employee Directors [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Nonvested shares, beginning balance | 35,364 | ||||
Granted | 14,742 | 0 | 0 | 30,000 | 14,742 |
Vested | (10,998) | ||||
Transferred | 0 | ||||
Forfeited/canceled | 0 | ||||
Nonvested shares, ending balance | 39,108 | ||||
Unrecognized stock-based compensation expense as of June 30, 2016 | $ 705 | ||||
Weighted average remaining vesting period (years) as of June 30, 2016 | 2 years 1 month 2 days | ||||
Restricted Stock Units (RSUs) [Member] | Employees [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Nonvested shares, beginning balance | 468,969 | ||||
Granted | 11,051 | 30,000 | 172,496 | 213,547 | |
Vested | (101,040) | ||||
Transferred | 0 | ||||
Forfeited/canceled | (6,974) | ||||
Nonvested shares, ending balance | 574,502 | ||||
Unrecognized stock-based compensation expense as of June 30, 2016 | $ 11,897 | ||||
Weighted average remaining vesting period (years) as of June 30, 2016 | 3 years 9 months 22 days | ||||
Restricted Stock Units (RSUs) [Member] | Independent Contractors [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Nonvested shares, beginning balance | 521,780 | ||||
Granted | 8,188 | 0 | 8,856 | 17,044 | |
Vested | (117,866) | ||||
Transferred | 0 | ||||
Forfeited/canceled | (4,135) | ||||
Nonvested shares, ending balance | 416,823 | ||||
Unrecognized stock-based compensation expense as of June 30, 2016 | $ 8,556 | ||||
Weighted average remaining vesting period (years) as of June 30, 2016 | 2 years 9 months 18 days |
Stock-Based Compensation Plan53
Stock-Based Compensation Plans - Outstanding Awards Under 2013 Omnibus Equity Incentive Plan (Parenthetical) (Detail) | 6 Months Ended |
Jun. 30, 2016 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Unrecognized stock-based compensation expenses recognition period | 3 years 4 months 6 days |
Stock-Based Compensation Plan54
Stock-Based Compensation Plans - Employee Stock Purchase Plan - Additional Information (Detail) | 6 Months Ended |
Jun. 30, 2016USD ($)shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Common stock shares available for issuance | 4,383,914 |
Unrecognized stock-based compensation expense | $ | $ 21,158,000 |
Unrecognized stock-based compensation expenses recognition period | 3 years 4 months 6 days |
Employee Stock Purchase Plan [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
ESPP offering period description | The offering periods generally start on the first trading day on or after May 15 and November 15 of each year. The first offering period began on May 15, 2014. |
Length of purchase intervals | 6 months |
ESPP discount rate | 10.00% |
Common stock reserved and available for issuance | 366,667 |
Common stock shares available for issuance | 289,244 |
Unrecognized stock-based compensation expense | $ | $ 81,000 |
Unrecognized stock-based compensation expenses recognition period | 4 months 17 days |
Stock-Based Compensation Plan55
Stock-Based Compensation Plans - Amendments to Restricted Stock and SARs - Additional Information (Detail) | 6 Months Ended |
Jun. 30, 2016 | |
Restricted Stock Sales Restriction [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Sales restriction lapse percentage for restricted stock | 20.00% |
Sales restriction period for restricted stock | 5 years |
Employee termination age | 67 years |
Percentage of shares of stock released from resale restriction upon consummation of change of control | 100.00% |
Percentage of shares of restricted released from resale restriction in the event of death or termination after reaching age 67 | 100.00% |
Deferred stock units [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Employee termination age | 67 years |
DSU settlement to common stock percentage | 20.00% |
DSU settlement into actual stock issued term | 5 years |
Percentage of shares of deferred stock units settled in the event of death or termination after reaching age 67 | 100.00% |
Stock-Based Compensation Plan56
Stock-Based Compensation Plans - Stock-Based Compensation Expense (Detail) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2016 | Jun. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2015 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based compensation expense - Independent contractors | $ 788 | $ 1,979 | $ 1,318 | $ 3,238 |
Allocated share-based compensation expense | 1,775 | 2,675 | 3,100 | 4,582 |
Employee Stock Purchase Plan [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Allocated share-based compensation expense | 60 | 66 | 108 | 128 |
Restricted Stock Awards [Member] | Non-Employee Directors [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Allocated share-based compensation expense | 109 | 78 | 198 | 137 |
Restricted Stock Units (RSUs) [Member] | Employees [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Allocated share-based compensation expense | $ 818 | $ 552 | $ 1,476 | $ 1,079 |
Stock-Based Compensation Plan57
Stock-Based Compensation Plans - Changes in Company's Common Stock Price During Reporting Period (Detail) - Stock Based Compensation Expense [Member] - $ / shares | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2016 | Jun. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2015 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Common stock price at beginning of period | $ 25.39 | $ 37.48 | $ 29.14 | $ 33.25 |
Common stock price at end of period | 25.41 | 46.14 | 25.41 | 46.14 |
Increase (decrease) in stock price | $ 0.02 | $ 8.66 | $ (3.73) | $ 12.89 |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Detail) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2016 | Jun. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2015 | |
Income Tax Disclosure [Abstract] | ||||
Effective income tax rate | 39.70% | 40.50% | 39.80% | 40.90% |
Earnings per Share - Computatio
Earnings per Share - Computation of Basic and Diluted Earnings Per Share, Including Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2016 | Jun. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2015 | |
Numerator (Basic and Diluted): | ||||
Net income | $ 17,524 | $ 17,556 | $ 32,339 | $ 31,225 |
Denominator: | ||||
Weighted average common shares issued and outstanding | 37,591 | 37,092 | 37,576 | 37,080 |
Deduct: Unvested RSAs | (38) | (44) | (36) | (44) |
Add: Fully vested DSUs | 1,365 | 1,822 | 1,365 | 1,822 |
Weighted Average Common Shares Outstanding | 38,918 | 38,870 | 38,905 | 38,858 |
Basic earnings per common share | $ 0.45 | $ 0.45 | $ 0.83 | $ 0.80 |
Weighted Average Common Shares Outstanding from above | 38,918 | 38,870 | 38,905 | 38,858 |
Add: Dilutive effect of RSUs, RSAs & ESPP | 136 | 187 | 103 | 148 |
Weighted Average Common Shares Outstanding | 39,054 | 39,057 | 39,008 | 39,006 |
Diluted earnings per common share | $ 0.45 | $ 0.45 | $ 0.83 | $ 0.80 |
Antidilutive shares excluded from diluted earnings per common share | 244 | 59 | 449 | 535 |
Earnings per Share - Computat60
Earnings per Share - Computation of Basic and Diluted Earnings Per Share, Including Antidilutive Securities Excluded from Computation of Earnings Per Share (Parenthetical) (Detail) | 1 Months Ended | 6 Months Ended |
Nov. 30, 2013 | Jun. 30, 2016 | |
Restricted Stock Awards [Member] | Non-Employee Directors [Member] | ||
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items] | ||
Vesting period | 3 years | 3 years |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information Credit Agreement (Detail) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2016 | Jun. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2015 | |
Line of Credit Facility [Line Items] | ||||
Senior secured revolving credit facility maximum borrowing capacity | $ 60,000,000 | $ 60,000,000 | ||
Revolving credit facility maturity date | Jun. 1, 2018 | |||
Date the Company entered into a Credit Agreement | Jun. 18, 2014 | |||
Credit agreement date | Jun. 1, 2014 | |||
Standby letters of credit borrowing capacity | 10,000,000 | $ 10,000,000 | ||
Standby letters of credit, utilized amount | 533,000 | $ 533,000 | ||
Credit facility interest rate description | Credit Facility bear interest, at the Company's option, at either the (i) Base Rate (defined as the highest of (a) the Bank's prime rate, (b) the Federal Funds Rate plus 1.5% and (c) one-month LIBOR plus 1.5%), or (ii) at a variable rate between 0.875% and 1.125% above LIBOR, based upon the total funded debt to EBITDA ratio. | |||
LIBOR rate duration period | 1 month | |||
Credit agreement, unused capacity, commitment fee percentage | 0.10% | |||
Interest expense | 384,000 | $ 386,000 | $ 775,000 | $ 969,000 |
Credit agreement, amount outstanding | 0 | $ 0 | ||
Credit facility covenants | (i) an EBITDAR Coverage Ratio (as defined in the Credit Agreement) of not less than 1.251.0 as of each quarter end and (ii) total funded debt to EBITDA not greater than 2.01.0 | |||
Minimum EBITDAR coverage ratio | 125.00% | |||
Maximum Total Funded Debt to EBITDA ratio | 200.00% | |||
Credit agreement, pledge percentage | 100.00% | |||
Compliance description | As of June 30, 2016, the Company was in compliance with all financial and non-financial covenants. | |||
Variable Rate Above (LIBOR) [Member] | ||||
Line of Credit Facility [Line Items] | ||||
Base spread on variable rate | 1.50% | |||
Federal Funds Rate [Member] | ||||
Line of Credit Facility [Line Items] | ||||
Base spread on variable rate | 1.50% | |||
Credit Agreement [Member] | ||||
Line of Credit Facility [Line Items] | ||||
Interest expense | $ 29,000 | $ 34,000 | $ 59,000 | $ 68,000 |
Minimum [Member] | Variable Rate Above (LIBOR) [Member] | ||||
Line of Credit Facility [Line Items] | ||||
Base spread on variable rate | 0.875% | |||
Maximum [Member] | Variable Rate Above (LIBOR) [Member] | ||||
Line of Credit Facility [Line Items] | ||||
Base spread on variable rate | 1.125% |